<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><front><journal-meta><journal-id journal-id-type="nlm-ta">PLoS ONE</journal-id><journal-id journal-id-type="publisher-id">plos</journal-id><journal-id journal-id-type="pmc">plosone</journal-id><journal-title>PLoS ONE</journal-title><issn pub-type="epub">1932-6203</issn><publisher><publisher-name>Public Library of Science</publisher-name><publisher-loc>San Francisco, USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">08-PONE-RA-05057R1</article-id><article-id pub-id-type="doi">10.1371/journal.pone.0004501</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="Discipline"><subject>Biochemistry</subject><subject>Cell Biology</subject><subject>Biochemistry/Chemical Biology of the Cell</subject><subject>Cell Biology/Cell Signaling</subject><subject>Immunology/Immunomodulation</subject><subject>Immunology/Innate Immunity</subject></subj-group></article-categories><title-group><article-title>Two Chromogranin A-Derived Peptides Induce Calcium Entry in Human Neutrophils by Calmodulin-Regulated Calcium Independent Phospholipase A<sub>2</sub></article-title><alt-title alt-title-type="running-head">Ca2&#x0002b; Entry in PMNs</alt-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Zhang</surname><given-names>Dan</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff5"><sup>5</sup></xref><xref ref-type="aff" rid="aff8"><sup>8</sup></xref></contrib><contrib contrib-type="author"><name><surname>Shooshtarizadeh</surname><given-names>Peiman</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Laventie</surname><given-names>Beno&#x000ee;t-Joseph</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Colin</surname><given-names>Didier Andr&#x000e9;</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chich</surname><given-names>Jean-Fran&#x000e7;ois</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vidic</surname><given-names>Jasmina</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>de Barry</surname><given-names>Jean</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chasserot-Golaz</surname><given-names>Sylvette</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Delalande</surname><given-names>Fran&#x000e7;ois</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Van Dorsselaer</surname><given-names>Alain</given-names></name><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><contrib contrib-type="author"><name><surname>Schneider</surname><given-names>Francis</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Helle</surname><given-names>Karen</given-names></name><xref ref-type="aff" rid="aff7"><sup>7</sup></xref></contrib><contrib contrib-type="author"><name><surname>Aunis</surname><given-names>Dominique</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Pr&#x000e9;vost</surname><given-names>Gilles</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Metz-Boutigue</surname><given-names>Marie-H&#x000e9;l&#x000e8;ne</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="corresp" rid="cor1"><sup>&#x0002a;</sup></xref></contrib></contrib-group><aff id="aff1"><label>1</label><addr-line>INSERM U575, Physiopathologie du Syst&#x000e8;me Nerveux, Strasbourg, France</addr-line></aff><aff id="aff2"><label>2</label><addr-line>UPRES-EA 3432, Institut de Bact&#x000e9;riologie de la Facult&#x000e9; de M&#x000e9;decine, Universit&#x000e9; Louis Pasteur, H&#x000f4;pitaux Universitaires de Strasbourg, Strasbourg, France</addr-line></aff><aff id="aff3"><label>3</label><addr-line>INRA, Virologie et Immunologie Mol&#x000e9;culaires, Jouy-en-Josas, France</addr-line></aff><aff id="aff4"><label>4</label><addr-line>Institut des Neurosciences Cellulaires et Int&#x000e9;gratives, UMR 7168 CNRS-Universit&#x000e9; Louis Pasteur, Strasbourg, France</addr-line></aff><aff id="aff5"><label>5</label><addr-line>D&#x000e9;partement de R&#x000e9;animation M&#x000e9;dicale, H&#x000f4;pital de Hautepierre, Strasbourg, France</addr-line></aff><aff id="aff6"><label>6</label><addr-line>Laboratoire de spectrom&#x000e9;trie de masse BioOrganique, IPHC-DSA, ULP, CNRS, UMR7178, Strasbourg, France</addr-line></aff><aff id="aff7"><label>7</label><addr-line>Department of Biomedicine, University of Bergen, Bergen, Norway</addr-line></aff><aff id="aff8"><label>8</label><addr-line>First Hospital, Chongqing University of Medical Sciences, Chongqing, China</addr-line></aff><contrib-group><contrib contrib-type="editor"><name><surname>Rojas</surname><given-names>Mauricio</given-names></name><role>Editor</role><xref ref-type="aff" rid="edit1"/></contrib></contrib-group><aff id="edit1">Emory University, United States of America</aff><author-notes><corresp id="cor1">&#x0002a; E-mail: <email>metz@neurochem.u-strasbg.fr</email></corresp><fn fn-type="con"><p>Conceived and designed the experiments: DAC JDB AVD FS DA GP MHMB. Performed the experiments: DZ BJL JV SCG FD. Analyzed the data: DZ PS BJL DAC JV JDB SCG KH GP MHMB. Contributed reagents/materials/analysis tools: PS DAC JFC JDB DA MHMB. Wrote the paper: DZ BJL JFC KH GP MHMB.</p></fn></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>19</day><month>2</month><year>2009</year></pub-date><volume>4</volume><issue>2</issue><elocation-id>e4501</elocation-id><history><date date-type="received"><day>11</day><month>6</month><year>2008</year></date><date date-type="accepted"><day>15</day><month>1</month><year>2009</year></date></history><copyright-statement>Zhang et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.</copyright-statement><copyright-year>2009</copyright-year><abstract><sec><title>Background</title><p>Antimicrobial peptides derived from the natural processing of chromogranin A (CgA) are co-secreted with catecholamines upon stimulation of chromaffin cells. Since PMNs play a central role in innate immunity, we examine responses by PMNs following stimulation by two antimicrobial CgA-derived peptides.</p></sec><sec><title>Methodology/Principal Findings</title><p>PMNs were treated with different concentrations of CgA-derived peptides in presence of several drugs. Calcium mobilization was observed by using flow cytometry and calcium imaging experiments. Immunocytochemistry and confocal microscopy have shown the intracellular localization of the peptides. The calmodulin-binding and iPLA2 activating properties of the peptides were shown by Surface Plasmon Resonance and iPLA2 activity assays. Finally, a proteomic analysis of the material released after PMNs treatment with CgA-derived peptides was performed by using HPLC and Nano-LC MS-MS. By using flow cytometry we first observed that after 15 s, in presence of extracellular calcium, Chromofungin (CHR) or Catestatin (CAT) induce a concentration-dependent transient increase of intracellular calcium. In contrast, in absence of extra cellular calcium the peptides are unable to induce calcium depletion from the stores after 10 minutes exposure. Treatment with 2-APB (2-aminoethoxydiphenyl borate), a store operated channels (SOCs) blocker, inhibits completely the calcium entry, as shown by calcium imaging. We also showed that they activate iPLA2 as the two CaM-binding factors (W7 and CMZ) and that the two sequences can be aligned with the two CaM-binding domains reported for iPLA2. We finally analyzed by HPLC and Nano-LC MS-MS the material released by PMNs following stimulation by CHR and CAT. We characterized several factors important for inflammation and innate immunity.</p></sec><sec><title>Conclusions/Significance</title><p>For the first time, we demonstrate that CHR and CAT, penetrate into PMNs, inducing extracellular calcium entry by a CaM-regulated iPLA2 pathway. Our study highlights the role of two CgA-derived peptides in the active communication between neuroendocrine and immune systems.</p></sec></abstract><counts><page-count count="14"/></counts></article-meta></front><body><sec id="s1"><title>Introduction</title><p>Chromogranin A (CgA) is a well-studied member of the chromogranin/secretogranin family, present in secretory cells of the nervous, endocrine and immune systems <xref ref-type="bibr" rid="pone.0004501-Helle1">&#x0005b;1&#x0005d;</xref>. CgA was the first chromogranin to be characterized as an acidic protein co-stored and co-released with the catecholamine hormones from the chromaffin cells of the adrenal medulla. The discovery that Pancreastatin, a CgA-derived peptide (bCGA<sub>248&#x02013;293</sub>) was able to inhibit the glucose-evoked insulin secretion from pancreatic beta-cells <xref ref-type="bibr" rid="pone.0004501-Tatemoto1">&#x0005b;2&#x0005d;</xref> initiated the concept of a prohormone function for this protein <xref ref-type="bibr" rid="pone.0004501-Eiden1">&#x0005b;3&#x0005d;</xref>. Numerous endogenous cleavage products of CgA have since been identified in the intragranular matrix of chromaffin cells, resulting from the proteolytic digestion at 13 sites <xref ref-type="bibr" rid="pone.0004501-Seidah1">&#x0005b;4&#x0005d;</xref> by intragranular enzymes, such as prohormone convertases PC1/3, PC2, neuroendocrine-specific carboxypeptidase E/H, Lys and Arg-aminopeptidases <xref ref-type="bibr" rid="pone.0004501-MetzBoutigue1">&#x0005b;5&#x0005d;</xref>. Among the CGA derived fragments, several induce biological activities <xref ref-type="bibr" rid="pone.0004501-Helle1">&#x0005b;1&#x0005d;</xref> an their <italic>in vitro</italic> actions strongly suggest involvement in homeostatic processes, such as calcium and glucose metabolisms <xref ref-type="bibr" rid="pone.0004501-Koeslag1">&#x0005b;6&#x0005d;</xref>, cardiovascular functions <xref ref-type="bibr" rid="pone.0004501-Aardal1">&#x0005b;7&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-Tota1">&#x0005b;11&#x0005d;</xref>, inflammatory reactions <xref ref-type="bibr" rid="pone.0004501-Blois1">&#x0005b;12&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Ferrero1">&#x0005b;13&#x0005d;</xref>, pain relief, tissue repair <xref ref-type="bibr" rid="pone.0004501-Gasparri1">&#x0005b;14&#x0005d;</xref>, gastrointestinal motility <xref ref-type="bibr" rid="pone.0004501-Amato1">&#x0005b;15&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Ghia1">&#x0005b;16&#x0005d;</xref> and in the first line of defence against invading microorganisms <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-MetzBoutigue2">&#x0005b;19&#x0005d;</xref>. The possible implication of CgA and some of its derived-peptides in human diseases has also been reviewed <xref ref-type="bibr" rid="pone.0004501-Taupenot1">&#x0005b;20&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Zhang1">&#x0005b;21&#x0005d;</xref>.</p><p>We have identified a range of antimicrobial peptides deriving from the natural processing, not only of CgA but also Chromogranin B, Proenkephalin-A and Ubiquitin co-secreted with catecholamines upon stimulation of chromaffin cells from the adrenal medulla <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Lugardon1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Goumon1">&#x0005b;22&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-Strub1">&#x0005b;25&#x0005d;</xref>. These new antimicrobial peptides are integrated in the concept that the adrenal medulla plays an important role in innate immunity <xref ref-type="bibr" rid="pone.0004501-Sternberg1">&#x0005b;26&#x0005d;</xref>. Furthermore, when polymorphonuclear neutrophils (PMNs), known to accumulate at sites of inflammation are stimulated by lipopolysaccharide or other bacterial agents, such as Panton-Valentine leucocidin (PVL) <xref ref-type="bibr" rid="pone.0004501-Genestier1">&#x0005b;27&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Joubert1">&#x0005b;28&#x0005d;</xref>, these cells produce and secrete intact and processed forms of CgA, such as Vasostatin-I and -II (residues 1&#x02013;76 and 1&#x02013;113) <xref ref-type="bibr" rid="pone.0004501-Lugardon1">&#x0005b;18&#x0005d;</xref> and Cateslytin (residues 344&#x02013;358) <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-JeanFrancois1">&#x0005b;29&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-JeanFrancois3">&#x0005b;31&#x0005d;</xref>, the N-terminal fragment of Catestatin (residues 344&#x02013;364) <xref ref-type="bibr" rid="pone.0004501-Mahata1">&#x0005b;32&#x0005d;</xref>. In view of the established function of PMNs as central effectors cells in innate immune responses to inflammatory stimuli, it is of a great importance to understand the implications of the production and secretion of CgA-derived peptides for the regulation of PMNs responses to external stimuli.</p><p>In the present study, we have investigated the effects of two of the potent antimicrobial CgA-derived peptides on activation of PMNs release, <italic>i.e.</italic>: Chromofungin (CHR, bovine/human CgA<sub>47&#x02013;66</sub>) <xref ref-type="bibr" rid="pone.0004501-Lugardon2">&#x0005b;24&#x0005d;</xref> and Catestatin (CAT, bovine CgA<sub>344&#x02013;364</sub>) <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>. By use of biochemical techniques, confocal microscopy, flow cytometry, calcium imaging, surface plasmon resonance and proteomic analyses, these two CgA peptides have now been demonstrated to stimulate exocytosis from PMNs by provoking a transient Ca<sup>2&#x0002b;</sup> entry independent of release from internal stores. The mechanism by which CHR and CAT may induce Ca<sup>2&#x0002b;</sup> influx appears to involve calmodulin (CaM) binding. The subsequent activation of the calcium-independent phospholipase A2 (iPLA2) in the complex regulation of store-operated channels (SOCs) <xref ref-type="bibr" rid="pone.0004501-Balsinde1">&#x0005b;33&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-Smani2">&#x0005b;37&#x0005d;</xref>, seemingly potentiates the release of a range of PMNs factors of importance identified by use of nanoLC-MS/MS.</p></sec><sec id="s2"><title>Results</title><p>Since PMNs are central effectors in innate immune response to inflammatory stimuli, we investigated the effects induced by two highly conserved antimicrobial CgA derived peptides on these cells. Chromofungin (CHR, RILSILRHQNLLKELQDLAL) corresponds to the active antifungal domain CgA<sub>47&#x02013;66</sub> of bovine and human Vasostatin-1 CgA<sub>1&#x02013;76</sub><xref ref-type="bibr" rid="pone.0004501-Lugardon2">&#x0005b;24&#x0005d;</xref> while Catestatin (CAT, RSMRLSFRARGYGFRGPGLQL) corresponds to a potent antimicrobial peptide CgA<sub>344&#x02013;364</sub> conserved in both cattle and man. These two peptides are not lytic for mammalian cells and display antimicrobial activities at the micromolar range <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Lugardon2">&#x0005b;24&#x0005d;</xref>.</p><sec id="s2a"><title>CHR and CAT provoked Ca<sup>2&#x0002b;</sup> entry in PMNs</title><p>In PMNs loaded with Fluo-3, a transient Ca<sup>2&#x0002b;</sup> influx was induced by 20 &#x000b5;M of either CHR or CAT (20 &#x000b5;M) in the presence, but not in the absence, of 1 mM free extracellular Ca<sup>2&#x0002b;</sup> (<xref ref-type="fig" rid="pone-0004501-g001">Figure 1A</xref>). Several other CgA-derived peptides (20 &#x000b5;M) were compared with CHR and CAT for influx of Ca<sup>2&#x0002b;</sup>. Three peptides derived from the N-terminal CgA domain failed to affect the Ca<sup>2&#x0002b;</sup> influx (<xref ref-type="fig" rid="pone-0004501-g001">Figure 1A</xref>). These peptides were: CgA<sub>4&#x02013;16</sub> (NSPMNKGDTEVMK), the disulfide loop CgA<sub>17&#x02013;40</sub> (CIVEVISDTLSKPSPMPVSKEC) and the natural peptide CgA<sub>65&#x02013;76</sub> (ALQGAKERTHQQ) previously reported to be without antimicrobial activities <xref ref-type="bibr" rid="pone.0004501-MetzBoutigue1">&#x0005b;5&#x0005d;</xref>. Furthermore, mixtures of peptides resulting from the tryptic digest of CHR (R, ILSILR, HQNLLK, ELQDLAL) and CAT (SSMK, LSFR, ARAYGFR, GPGPQL) were without effect on Ca<sup>2&#x0002b;</sup> influx<sup>,</sup> nor was scrambled CAT peptide (SLPRRQLPSSAGMRGGKFAYF) of any effect (<xref ref-type="fig" rid="pone-0004501-g001">Figure 1A</xref>). Hence, the complete sequences of CHR and CAT appear to be essential for the induction of the transient Ca<sup>2&#x0002b;</sup> influx.</p><fig id="pone-0004501-g001" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g001</object-id><label>Figure 1</label><caption><title>Ca<sup>2&#x0002b;</sup> influx evoked in human PMNs by CGA-derived peptides.</title><p>For flow cytometry analysis, human PMNs (5.10<sup>5</sup> cells/ml) were loaded with Fluo-3AM probe (5 &#x000b5;M) and its fluorescence intensity of Fluo-3 was monitored at &#x003bb;<sub>Em530 nm</sub>. Traces were obtained from 3000 PMNs and are averaged from triplicates at least. Peptides were added in the Ca<sup>2&#x0002b;</sup>-free EGTA buffer at t&#x0200a;&#x0003d;&#x0200a;0 and 1.1 mM CaCl<sub>2</sub> at t&#x0200a;&#x0003d;&#x0200a;620 s. A) Time course variations of the intracellular Ca<sup>2&#x0002b;</sup> in human PMNs in response to 20 &#x000b5;M CAT or 20 &#x000b5;M CHR and compared with other CgA-derived peptides (20 &#x000b5;M of CgA<sub>4&#x02013;16</sub>, CgA<sub>17&#x02013;40</sub> or CgA<sub>65&#x02013;76</sub>), tryptic digests of either 20 &#x000b5;M CAT, CHR or scrambled CAT. B, C) Time course variations of the intracellular Ca<sup>2&#x0002b;</sup> in human PMNs in response to increasing concentrations (1&#x02013;200 &#x000b5;M) of CHR (B), CAT (C) or a mixture of 50 &#x000b5;M CAT and 50 &#x000b5;M CHR (C).</p></caption><graphic xlink:href="pone.0004501.g001"/></fig><p>The inducing effects of CHR and CAT on the Ca<sup>2&#x0002b;</sup> influx were concentration-dependent in the 5&#x02013;200 &#x000b5;M range (<xref ref-type="fig" rid="pone-0004501-g001">Figure 1B, C</xref>). Interestingly, the simultaneous addition of CHR and CAT at equal concentrations provoked a higher Ca<sup>2&#x0002b;</sup> increase (<xref ref-type="fig" rid="pone-0004501-g001">Figure 1C</xref>) than the sum of effects observed by separately added peptides (<xref ref-type="fig" rid="pone-0004501-g001">Figure 1B and C</xref>), suggesting that CHR and CAT may have synergic effects on the transient Ca<sup>2&#x0002b;</sup> entry in PMNs.</p><p>An immediate increase of activated PMNs (M1/M2) was observed 15 s after the application of either CHR or CAT (<xref ref-type="fig" rid="pone-0004501-g002">Figure 2A</xref>). With different concentrations of CHR or CAT (0&#x02013;200 &#x000b5;M), the percentage of activated PMNs was concentration dependent, being maximal at 50 &#x000b5;M for CHR (45&#x00025;) and CAT (60&#x00025;), respectively (<xref ref-type="fig" rid="pone-0004501-g002">Figure 2B</xref>).</p><fig id="pone-0004501-g002" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g002</object-id><label>Figure 2</label><caption><title>Concentration-dependent Ca<sup>2&#x0002b;</sup>-influx after stimulation of human PMNs by CHR and CAT.</title><p>A) Representative diagrams of flow cytometry determination of the Ca<sup>2&#x0002b;</sup> influx in the basic (M1) and peptide-activated (M2) windows, respectively. These influxes (in black) were obtained 15 s after the addition of 50 &#x000b5;M CHR or 50 &#x000b5;M CAT at t&#x0200a;&#x0003d;&#x0200a;0 (in grey). PMNs activated by peptide-induced Ca<sup>2&#x0002b;</sup> influx correspond to the M2 population. B) Flow cytometry quantification of PMNs in the M2 window in percent of the total initial population of PMNs, after 15 s exposure to increasing concentrations of CHR or CAT (1&#x02013;200 &#x000b5;M).</p></caption><graphic xlink:href="pone.0004501.g002"/></fig></sec><sec id="s2b"><title>Ca<sup>2&#x0002b;</sup> entry evoked by CHR and CAT via Ca<sup>2&#x0002b;</sup> selective Store Operated Calcium channels (SOCs)</title><p>Pretreatment of PMNs with the specific blocker of SOCs, 2-aminoethyl diphenylborinate (2-APB) for 2 min before addition of peptides, completely blocked the entry of extracellular Ca<sup>2&#x0002b;</sup> by CHR or CAT (<xref ref-type="fig" rid="pone-0004501-g003">Figure 3A and 3B</xref>), suggesting that the two peptides were involved in the activation of Store Operated Calcium Entry (SOCE) through SOCs. Ca<sup>2&#x0002b;</sup> entry in response to CHR and CAT was also compared to that induced by Arachidonic Acid (AA), acting through the Arachidonic-Regulated Channels (ARCs) (<xref ref-type="fig" rid="pone-0004501-g003">Fig 3C</xref>). The calcium influx induced by 50 &#x000b5;M AA was insensitive to 2-APB, while inhibited by gadolinium chloride (Gd<sup>3&#x0002b;</sup>), in marked contrast to the influx induced by CHR or CAT (<xref ref-type="fig" rid="pone-0004501-g003">Figure 3A&#x02013;C</xref>). Thus, the Ca<sup>2&#x0002b;</sup>- entry induced by the two CgA-derived peptides was pharmacologically distinct from that by AA.</p><fig id="pone-0004501-g003" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g003</object-id><label>Figure 3</label><caption><title>Ca<sup>2&#x0002b;</sup> influx in PMNs induced by CHR, and CAT and arachidonic acid (AA).</title><p>Time-lapse intracellular calcium imaging was performed on cells loaded with 1 &#x000b5;M Fura-2-AM and then further treated with 20 &#x000b5;M CHR, 20 &#x000b5;M CAT and 50 &#x000b5;M (AA) in Hepes-buffered Krebs medium in presence of 2.5 mM CaCl<sub>2</sub>. A&#x02013;C) Left panels, Representative traces showing average change in &#x0005b;Ca<sup>2&#x0002b;</sup>&#x0005d;<sub>i</sub> (F<sub>340nm</sub>/F<sub>380nm</sub>) recorded in the ratio mode from individual PMNs loaded with Fura-2. The arrow indicates the time of addition of 20 &#x000b5;M CHR, 20 &#x000b5;M CAT and 50 &#x000b5;M AA. In separate assays (as indicated) either 100 &#x000b5;M 2-aminoethyl diphenylborinate (2-APB) or 1 &#x000b5;M gadolinium chloride (Gd<sup>3&#x0002b;</sup>) were applied 2 min before addition of peptides or AA. Traces are averaged from triplicates. Right panels, Summary of data in left panels, showing the maximal Ca<sup>2&#x0002b;</sup> influx (mean ratio&#x000b1;S.E.) obtained with the different conditions as indicated below bars. (n), number of PMNs used for each experiment; &#x0002a;, indicate significant differences (<italic>p</italic>&#x0003c;0.05), significance for difference from effect of CHR, CAT or AA alone.</p></caption><graphic xlink:href="pone.0004501.g003"/></fig><p>Finally, the specificity for divalent cation entry into PMNs loaded with Fura-2 was assessed by comparison of the peptide induced Ca<sup>2&#x0002b;</sup> entry (traces a and b) with that of Mn<sup>2&#x0002b;</sup> (traces c and d) at the corresponding wavelengths of excitation (&#x003bb;<sub>ex340nm</sub> and &#x003bb;<sub>ex360nm</sub>) (<xref ref-type="fig" rid="pone-0004501-g004">Figure 4</xref>). By comparison of the traces for CAT (a, c) and CHR (b,d) there was no evidence for Mn<sup>2&#x0002b;</sup> entry in response to either peptide, consistent with activation of SOCs selective for Ca<sup>2&#x0002b;</sup> and non-permeable for Mn<sup>2&#x0002b;</sup> in PMNs <xref ref-type="bibr" rid="pone.0004501-Itagaki1">&#x0005b;38&#x0005d;</xref>.</p><fig id="pone-0004501-g004" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g004</object-id><label>Figure 4</label><caption><title>Specificity of the Ca<sup>2&#x0002b;</sup> entry provoked by 50 &#x000b5;M CHR and 20 &#x000b5;M CAT.</title><p>Characterization by spectrofluorimetry of the specificity of the Ca<sup>2&#x0002b;</sup> entry induced by 50 &#x000b5;M CHR or 20 &#x000b5;M CAT for comparison with peptide effects on Mn<sup>2&#x0002b;</sup> entry. Simultaneous recordings of fluorescent intensity variations of PMNs loaded with Fura-2 in the presence of 1 mM CaCl<sub>2</sub> (a, b) and 0.2 mM MnCl<sub>2</sub> (c, d) at the corresponding wavelengths of excitation &#x003bb;<sub>Ex340 nm</sub> and &#x003bb;<sub>Ex360 nm</sub>. Divalent cations and peptides were added as indicated by arrows. Recordings are representative of three experiments.</p></caption><graphic xlink:href="pone.0004501.g004"/></fig></sec><sec id="s2c"><title>Calmodulin binding of CHR and CAT</title><p>The uptake of rhodamine-labeled CHR and CAT into isolated PMNs was demonstrated by confocal microscopy (<xref ref-type="fig" rid="pone-0004501-g005">Figure 5A</xref>). After 2 min incubation, the fluorescent rhodamine-labeled peptides were detected in the cytoplasm. In contrast, the control peptide, rhodamine-labeled Hippocampal Cholinergic Neurostimulating Peptide (HCNP), unable to induce Ca<sup>2&#x0002b;</sup> influx into PMNs (not shown), was not detected in the cytoplasm, indicating a specificity for the entry of rhodamine-labeled CHR and CAT (<xref ref-type="fig" rid="pone-0004501-g005">Figure 5A</xref>).</p><fig id="pone-0004501-g005" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g005</object-id><label>Figure 5</label><caption><title>Interaction of CHR and CAT with calmodulin (CaM).</title><p>A) Fluorescence confocal microscopy of PMNs after incubation during 120 s with 20 &#x000b5;M rhodamine-labeled peptides (Rho-CHR or Rho-CAT). Control peptide: 20 &#x000b5;M rhodamine labeled Hippocampal Cholinergic Neurostimulating Peptide (Rho-HCNP). The PMNs nuclei were labeled with Draq-5. B) Alignment of the CHR and CAT sequences with two CaM binding motifs 1-8-14 B and 1-5-10. The alignment has been obtained manually so that hydrophobic residues occupy invariant positions shown with boldface letters. The net positive charge is also indicated. C) (1) Interactions between CaM, CAT and CHR by Surface Plasmon Resonance (SPR) Peptides were immobilized on a CM5 Biacore chip using amine-coupling chemistry. CaM (5 &#x000b5;M) was added at arrow and allowed to stabilize for 10 min. Dissociation by washing was recorded for the following 10 min. All measurements were performed at 20&#x000b0;C. The resulting sensorgrams were analyzed using BIAevaluation Software. (2) Calmodulin-Affinity Chromatography of CHR and CAT. The retained and eluted peptides were immunodetected by dot blot with anti-CHR (monoclonal anti-CgA<sub>47&#x02013;68</sub>) and anti-CAT (polyclonal anti-CgA<sub>344&#x02013;364</sub>). Wash (5<sup>th</sup> wash after adsorption of peptides).</p></caption><graphic xlink:href="pone.0004501.g005"/></fig><p>The two cationic sequences CAT and CHR may be aligned with two Ca<sup>2&#x0002b;</sup>- dependent CaM binding motifs 1-8-14 B and 1-5-10 <xref ref-type="bibr" rid="pone.0004501-Rhoads1">&#x0005b;39&#x0005d;</xref>, as illustrated in <xref ref-type="fig" rid="pone-0004501-g005">Figure 5</xref> B and previously demonstrated for binding of CHR to CaM <xref ref-type="bibr" rid="pone.0004501-Lugardon2">&#x0005b;24&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Yoo1">&#x0005b;40&#x0005d;</xref>. Interactions between CaM, CAT and CHR were assessed by surface plasmon resonance (SPR) (<xref ref-type="fig" rid="pone-0004501-g005">Figure 5 C1</xref>), revealing that not only CHR but also CAT specifically interacted with CaM, while scrambled CAT was inactive. In addition, CaM interacts with both CHR and CAT (<xref ref-type="fig" rid="pone-0004501-g005">Figure 5C2</xref>) when assayed by CaM-binding affinity chromatography and dot blot immunodetection of CgA in the fixed material with anti-CHR (monoclonal anti-CGA<sub>47&#x02013;66</sub>) <xref ref-type="bibr" rid="pone.0004501-Gasparri1">&#x0005b;14&#x0005d;</xref> and anti-CAT (polyclonal anti-CGA<sub>344&#x02013;364</sub>) <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>.</p></sec><sec id="s2d"><title>Role of iPLA<sub>2</sub> in the Ca<sup>2&#x0002b;</sup> entry evoked by CHR and CAT</title><p>Previous studies have demonstrated that functional iPLA<sub>2</sub> is involved in activation of SOCs from different cell types <xref ref-type="bibr" rid="pone.0004501-Smani2">&#x0005b;37&#x0005d;</xref> and that displacement of inhibitory CaM from iPLA<sub>2</sub> may activate iPLA<sub>2</sub>, subsequently generating of lysophospholipids for activation of SOCs <xref ref-type="bibr" rid="pone.0004501-Smani1">&#x0005b;36&#x0005d;</xref>. Confocal microscopy confirmed the presence of immunoreactive iPLA<sub>2</sub> in PMNs (<xref ref-type="fig" rid="pone-0004501-g006">Figure 6A, right panel</xref>). The membrane localization of immunoreactive iPLA<sub>2</sub> could be verified after subcellular fractionation, Triton X-100 treatment and western blotting (<xref ref-type="fig" rid="pone-0004501-g006">Figure 6B</xref>, <xref ref-type="bibr" rid="pone.0004501-Smani1">&#x0005b;36&#x0005d;</xref>). The enzymatic activity of iPLA<sub>2</sub> in PMNs was stimulated not only by two CaM inhibitors, <italic>i.e.</italic> calmidazolium (CMZ) and N-(6-aminohexyl)-5-chloro-l-naphthalenesulfonamide (W7), but also by CHR and CAT (<xref ref-type="fig" rid="pone-0004501-g006">Figure 6C</xref>). Interestingly, a comparison of CHR and CAT sequences with two CaM-binding peptides of iPLA<sub>2</sub> reveals marked homologies (<xref ref-type="fig" rid="pone-0004501-g006">Figure 6D</xref>). Of note, the CHR sequence may be aligned with one of the iPLA<sub>2</sub> CaM-binding motif (iPLA2<sub>618&#x02013;635</sub>), while the CAT sequence aligns with another, <italic>i.e.</italic> the iPLA<sub>2</sub> CaM-binding motif (iPLA2<sub>691&#x02013;709</sub>) <xref ref-type="bibr" rid="pone.0004501-Jenkins1">&#x0005b;41&#x0005d;</xref>.</p><fig id="pone-0004501-g006" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g006</object-id><label>Figure 6</label><caption><title>CHR and CAT stimulate iPLA2 activity.</title><p>A) Fluorescence confocal microscopy of PMNs: Left, PMNs treated only with the secondary antibody (Alexa Fluo 488-conjugated donkey anti-rabbit IgG dilution 1&#x02236;2000). Right, PMNs stained with polyclonal anti-iPLA<sub>2</sub> as primary antibody before Alexa Fluo 488 conjugated donkey anti-rabbit IgG. B) Western-blot analysis: The presence of a 82 kDa protein corresponding to iPLA<sub>2</sub> was immunodetected in the membrane fraction obtained from PMNs. A comparable signal was obtained from the supernatant fraction of membranes treated with 0.1&#x00025; Triton X-100. C) iPLA<sub>2</sub> activity assay: Stimulation of iPLA<sub>2</sub> activity after treatment by 20 &#x000b5;M CHR or 20 &#x000b5;M CAT for 30 min at 37&#x000b0;C and comparison with the effects of two CaM-binding factors (1 &#x000b5;M CMZ, 50 &#x000b5;M W7) and one iPLA<sub>2</sub> inhibitor (25 &#x000b5;M BEL). Activity of iPLA<sub>2</sub> is expressed as the absorbance (Abs/mg of protein) at &#x003bb;<sub>405 nm</sub>. Results from two similar experiments, each performed in triplicate are presented as mean&#x000b1;S.E. &#x0002a; p&#x0003c;0.05, significance for difference from controls. D) Alignment of CHR and CAT sequences with two CaM-binding peptides of iPLA<sub>2</sub>. CHR sequence has been aligned with the iPLA<sub>2</sub> CaM-binding motif aa 618 to aa 635 while the CAT sequence has been aligned with the iPLA<sub>2</sub> CaM-binding motif (691&#x02013;709). Corresponding homologous residues are in bold and underlined fonts.</p></caption><graphic xlink:href="pone.0004501.g006"/></fig></sec><sec id="s2e"><title>CHR and CAT directly activate SOCs via iPLA<sub>2</sub></title><p>Two inhibitors of iPLA<sub>2</sub> were compared with 2-APB for effects on peptide inducing Ca<sup>2&#x0002b;</sup> influx (<xref ref-type="fig" rid="pone-0004501-g006">Figure 6C</xref>, <xref ref-type="fig" rid="pone-0004501-g007">7A, B</xref>). Bromoenol lactone (BEL), a specific inhibitor of iPLA<sub>2</sub> and bromophenacyl bromide (BPB), an inhibitor of PLA<sub>2</sub>, abolished the transient Ca<sup>2&#x0002b;</sup> influx induced by CHR or CAT similarly to 2-APB. In addition, the two CaM antagonists W7 and CMZ induced longer lasting rises in influx (<xref ref-type="fig" rid="pone-0004501-g007">Figure 7C, D</xref>), that were significantly suppressed by the PLA<sub>2</sub> inhibitors BEL and BPB and the specific SOC blocker 2-APB.</p><fig id="pone-0004501-g007" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g007</object-id><label>Figure 7</label><caption><title>Involvement of iPLA<sub>2</sub> in Ca<sup>2&#x0002b;</sup> entry evoked by CHR and CAT in PMNs.</title><p>A&#x02013;D) Left panels: Effects of the SOC blocker (100 &#x000b5;M 2-APB) and inhibitors of iPLA<sub>2</sub> (25 &#x000b5;M BEL) and PLA<sub>2</sub> (10 &#x000b5;M BPB) on Ca<sup>2&#x0002b;</sup> entry evoked by 20 &#x000b5;M of CHR or CAT, and two CaM antagonists (30 &#x000b5;M W7 and 1 &#x000b5;M CMZ). The representative traces show the average change in intracellular Ca<sup>2&#x0002b;</sup> concentration (Fura-2 ratio, F<sub>340</sub>/F<sub>380</sub>) recorded simultaneously in a number of individual PMNs at 37&#x000b0;C. The following inhibitors were added: BEL (30 min), BPB (10 min) and 100 &#x000b5;M 2-APB (2 min) before addition of peptides or CaM antagonists (at arrows). Results are obtained from at least three independent experiments. Right panels: Bars represent the maximum Ca<sup>2&#x0002b;</sup> influx (Ratio&#x000b1;S.E.) in different treatments (indicated below each bar); (n) number of PMNs; &#x0002a; <italic>p</italic>&#x0003c;0.05, significance for difference from peptide or CaM antagonist alone.</p></caption><graphic xlink:href="pone.0004501.g007"/></fig><p>Interestingly, CMZ and some CaM inhibitory peptides may directly activate SOCs without the release of intracellular Ca<sup>2&#x0002b;</sup> stores <xref ref-type="bibr" rid="pone.0004501-Bolotina1">&#x0005b;42&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-Csutora1">&#x0005b;44&#x0005d;</xref>. Hence, these findings indicate that CAT and CHR, being unable to evoke a Ca<sup>2&#x0002b;</sup> mobilization from intracellular stores in absence of extracellular Ca<sup>2&#x0002b;</sup>, by their 2-APB sensitive induction of Ca<sup>2&#x0002b;</sup> entry <italic>via</italic> SOCs may converge on iPLA<sub>2</sub> in a manner similar to the two CaM inhibitors W7 and CMZ.</p></sec><sec id="s2f"><title>Proteomic analysis of the PMNs secretions released by CHR and CAT</title><p>PMNs secretions obtained after treatment with CHR and CAT were chromatographied by HPLC (<xref ref-type="fig" rid="pone-0004501-g008">Figure 8A, B</xref>) and the isolated fractions were identified by NanoLC-MS/MS analysis (supplementary data). Factors involved in innate immunity were identified among these proteins, <italic>i.e.</italic> lactotransferrin, lysozyme, neutrophil gelatinase associated lipocalin, S100 calcium binding protein A8, S100 calcium binding protein A9, heat shock 70 kDa protein and leukotriene A4 hydrolase (<xref ref-type="fig" rid="pone-0004501-g008">Figure 8C</xref> and complete data in the annexe with <xref ref-type="supplementary-material" rid="pone.0004501.s001">Figures S1</xref> and <xref ref-type="supplementary-material" rid="pone.0004501.s002">S2</xref>).</p><fig id="pone-0004501-g008" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g008</object-id><label>Figure 8</label><caption><title>HPLC of proteins in PMNs secretions induced by CHR and CAT and implication for innate immunity.</title><p>A, B) Secretion from PMNs (1.10<sup>8</sup> cells) was induced during 30 min stimulation by (A) 20 &#x000b5;M CHR or (B) 20 &#x000b5;M CAT. The secreted proteins &#x0003e;3 kDa were purified by RP-HPLC on a Macherey Nagel reverse-phase C18 column (4&#x000d7;250 mm; particle size 5 &#x000b5;M and pore size 100 nm). Numbered peaks in the chromatograms indicate protein fractions subjected to proteomic analyses. (C) Proteomic identification by NanoLC-MS/MS analysis of protein fractions involved in innate immunity (protein identification probability &#x0003e;93&#x00025;). The numbered HPLC fractions correspond to the peaks of secreted protein in the chromatograms presented in A and B, respectively.</p></caption><graphic xlink:href="pone.0004501.g008"/></fig><p>CgA-derived fragments in the PMN secretions obtained after treatment with CHR and CAT were detected by western blotting, revealing traces of Vasostatin-1 and a CAT-including fragment (CgA<sub>340&#x02013;395</sub>) (data not shown), consistent with the previously report of several CAT-including peptides with molecular weights in the range 70-15 kDa <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>. The major fragment corresponds to CgA<sub>340&#x02013;395</sub> (15&#x02013;17 kDa) after stimulation of PMNs by CAT.</p></sec></sec><sec id="s3"><title>Discussion</title><p>The present experiments are the first to demonstrate that not only CAT but also the distinctly different sequence CHR may play a role in Ca<sup>2&#x0002b;</sup> signaling outside the chromaffin cells, <italic>i.e.</italic> serving as immunomodulators for activation of PMNs secretion.</p><p>A rapid and effective response to challenge with pathogens is essential for the survival of all living organisms. Natural cationic host defense peptides represent lead molecules that boost innate immune responses and selectively modulate pathogen-induced inflammatory responses <xref ref-type="bibr" rid="pone.0004501-Mookherjee1">&#x0005b;45&#x0005d;</xref>. Among the different mechanisms that have evolved to this effect, the production of a large variety of natural antimicrobial peptides has gained increasing attention.</p><p>CHR and CAT are two antimicrobial peptides derived from CgA. They are stored in secretory granules of chromaffin cells and PMNs in a larger form, which may be processed extracellularly to the mature active peptides <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Lugardon1">&#x0005b;18&#x0005d;</xref>. In the intragranular matrix, they result to the processing of CgA by numerous enzymes such as prohormone convertases (PC1 and 2), aminopeptidases and carboxypeptidases. In the extracellular medium, larger forms may be processed by kallikrein located at the plasmic membrane level and by circulatory proteolytic enzymes such as plasmin and thrombin <xref ref-type="bibr" rid="pone.0004501-Helle1">&#x0005b;1&#x0005d;</xref>. In addition, some bacterial virulence factors are indeed proteolytic enzymes, <italic>i.e.</italic> Glu-C protease from <italic>Staphylococcus aureus,</italic> and might continue the natural processing of CgA to generate the CHR and CAT fragments during infections <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Lugardon1">&#x0005b;18&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Radek1">&#x0005b;46&#x0005d;</xref>.</p><p>To date only CAT has been reported to act <italic>via</italic> a classical surface receptor, <italic>i.e.</italic> the nicotinic acetylcholine receptor <xref ref-type="bibr" rid="pone.0004501-Mahata1">&#x0005b;32&#x0005d;</xref>. On the other hand, several 70&#x02013;80 kDa membrane binding proteins have been reported for Vasostatin-I (CgA<sub>1&#x02013;76</sub>) <xref ref-type="bibr" rid="pone.0004501-Angeletti1">&#x0005b;47&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Russell1">&#x0005b;48&#x0005d;</xref>. Furthermore, the sequences of CHR and CAT may also be aligned with the cell penetrating peptide (CPP), Penetratin, <italic>i.e.</italic> (<xref ref-type="fig" rid="pone-0004501-g009">Figure 9</xref> insert), pointing the possibility for CHR and CAT, as new members of the family of CPPs <xref ref-type="bibr" rid="pone.0004501-Henriques1">&#x0005b;49&#x0005d;</xref>.</p><fig id="pone-0004501-g009" position="float"><object-id pub-id-type="doi">10.1371/journal.pone.0004501.g009</object-id><label>Figure 9</label><caption><title>Model for the action of CHR and CAT on PMNs activation.</title><p>Stress and infection lead to two different pathways for stimulation of PMN secretion, by release of CgA and CgA-derived peptides from the adrenal medulla, as indicated by 1a&#x02013;6a (black), and by PVL leucocidin stimulation by <italic>S. aureus infections</italic>, as indicated by 1b&#x02013;3b (grey), respectively. Abbreviated symbols: P (CHR, CAT), P' (CAT), CPP (Cell Penetrating Peptide), CaM (calmodulin), iPLA<sub>2</sub> (calcium independent phospholipase A<sub>2</sub>) LysoPL (lysophospholipids); GC (Golgi complex); PVL (Panton-Valentine leucocidin), R (receptor). The stress-stimulated pathway leads to penetration of P into the cytoplasm (2a), resulting in removal of inhibitory CaM, activation of iPLA<sub>2</sub> to produce LysoPL (3a) and activation of Ca<sup>2&#x0002b;</sup> influx through SOC (4a), converging on activated docking of secretory granules (5a) and subsequent release of proteins of relevance for innate immunity (6a). The negative feedback induced by P' on nicotinic cholinergic receptor of chromaffin cell is also indicated (7a). The infective route leads to activation of the putative PVL receptor coupled to opening of Ca<sup>2&#x0002b;</sup>-channels and a rise in intracellular Ca<sup>2&#x0002b;</sup> (3b) that converges on docking of secretory granules and subsequent secretion of proteins of relevance for innate immunity (6a). Transcription of CgA in response to stress and infection is also indicated. Insert.The alignment of the two P sequences (CHR and CAT) with that of Penetratin (Cell penetrating peptide, CPP).</p></caption><graphic xlink:href="pone.0004501.g009"/></fig><p>Calcium is an universal secondary messenger involved in many cellular signal transduction pathways, regulating crucial functions such as secretion, cell motility, proliferation and cell death. Increased in intracellular Ca<sup>2&#x0002b;</sup> derives mainly from two sources: internal stores releasing Ca<sup>2&#x0002b;</sup> into the cytosol and channels in the plasma membrane that open to allow external Ca<sup>2&#x0002b;</sup> to flow into the cell. In PMNs, calcium signaling has been reported to be involved in oxidase activation, cell degranulation and priming response to a wide variety of proinflammatory molecules <xref ref-type="bibr" rid="pone.0004501-Parekh1">&#x0005b;35&#x0005d;</xref>. The present experiments have demonstrated that the two CgA peptides, CHR and CAT, penetrate rapidly into PMNs (<xref ref-type="fig" rid="pone-0004501-g005">Figure 5A</xref>) and subsequently interact with CaM (<xref ref-type="fig" rid="pone-0004501-g005">Figure 5C</xref>) to activate iPLA<sub>2</sub> (<xref ref-type="fig" rid="pone-0004501-g006">Figure 6C</xref>). Displacement of CaM leads to iPLA<sub>2</sub> activation and production of lysophospholipids inducing the opening of SOCs <xref ref-type="bibr" rid="pone.0004501-Smani1">&#x0005b;36&#x0005d;</xref>, the entry of Ca<sup>2&#x0002b;</sup> and the release of innate immune factors among a long list of proteins (<xref ref-type="fig" rid="pone-0004501-g008">Figure 8C</xref> and <xref ref-type="supplementary-material" rid="pone.0004501.s001">Figures S1</xref> and <xref ref-type="supplementary-material" rid="pone.0004501.s002">S2</xref>).</p><p>The SOCE pathway remains one of the most intriguing and long lasting mysteries of Ca<sup>2&#x0002b;</sup> signaling <xref ref-type="bibr" rid="pone.0004501-Bolotina2">&#x0005b;43&#x0005d;</xref>. The main question concerns the origin of the signal <xref ref-type="bibr" rid="pone.0004501-Bolotina2">&#x0005b;43&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Lewis1">&#x0005b;50&#x0005d;</xref>: how does depletion of the internal Ca<sup>2&#x0002b;</sup> store activate Ca<sup>2&#x0002b;</sup> entry through the SOC in the plasma membrane?. The Calcium Influx Factor (CIF) is a specific factor produced by the cells following depletion of Ca<sup>2&#x0002b;</sup> stores <xref ref-type="bibr" rid="pone.0004501-Randriamampita1">&#x0005b;51&#x0005d;</xref> and corresponds to the diffusible messenger that is produced by Ca<sup>2&#x0002b;</sup> stores upon their depletion traveling to the plasma membrane to activate SOCs and Ca<sup>2&#x0002b;</sup> entry <xref ref-type="bibr" rid="pone.0004501-Bolotina2">&#x0005b;43&#x0005d;</xref>. The mechanism by CIF may activate SOCs with a displacement of CaM from the inactive complex with iPLA<sub>2</sub>. The subsequent formation of lysophospholipids and the opening of SOCs, consistent with an activation of SOCs by displacement of inhibitory CAM from the inactive complex with iPLA<sub>2</sub><xref ref-type="bibr" rid="pone.0004501-Smani1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Smani2">&#x0005b;37&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Bolotina2">&#x0005b;43&#x0005d;</xref>. Thus, CaM inhibitors such as chemical substances and peptides, may activate SOCs by interfering with the CaM-iPLA<sub>2</sub> complex <xref ref-type="bibr" rid="pone.0004501-Smani1">&#x0005b;36&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Bolotina2">&#x0005b;43&#x0005d;</xref>. The present experiments have made evident that CHR and CAT induce a 2-APB sensitive Ca<sup>2&#x0002b;</sup> entry without depletion of Ca<sup>2&#x0002b;</sup> stores in a similar manner to CaM inhibitors, pointing to iPLA<sub>2</sub>, as the most likely target for these two peptides, once penetrated into the cytoplasm.</p><p>Of note, CAT is an inhibitory peptide controlling catecholamine release from chromaffin cells and noradrenergic neurons by an autocrine regulatory mechanism, non-competitively blocking the influx of Ca<sup>2&#x0002b;</sup> coupled to activation of the nicotinic acetylcholine receptor, as illustrated in <xref ref-type="fig" rid="pone-0004501-g009">Figure 9</xref>, but not when triggered by membrane depolarization <xref ref-type="bibr" rid="pone.0004501-Mahata1">&#x0005b;32&#x0005d;</xref>.</p><p>Several proteins involved in innate immunity (lactotransferrin, heat shock 70 kDa protein, lysosyme, neutrophil gelatinase associated lipocalin, protein S100-A8, protein S100-A9 and leukotriene A-4 hydrolase were identified by using proteomic analysis in the secretions of neutrophils stimulated by CHR and CAT (<xref ref-type="fig" rid="pone-0004501-g008">Figure 8C</xref>). In neutrophils, azurophil, specific and gelatinase granules contain host defense proteins in their luminal spaces. The extent of mobilization of the three types of granules depends on the stimulus intensity: gelatinase granules are most easily mobilized followed by specific granules and then azurophil granules.</p><p>Lactotransferrin is an iron-binding protein that is released from activated neutrophils at sites of inflammation by the three types of granules <xref ref-type="bibr" rid="pone.0004501-Lominadze1">&#x0005b;52&#x0005d;</xref> and has antimicrobial, as well as anti-inflammatory properties <xref ref-type="bibr" rid="pone.0004501-Wong1">&#x0005b;53&#x0005d;</xref>. Lactotransferrin serves as an autoregulator to retain PMNs at inflammatory sites <xref ref-type="bibr" rid="pone.0004501-delaRosa1">&#x0005b;54&#x0005d;</xref> and it was able to delay spontaneous apoptosis of neutrophils <xref ref-type="bibr" rid="pone.0004501-Oseas1">&#x0005b;55&#x0005d;</xref>. The anti-inflammatory activity of lactotransferrin is due to binding and neutralization of proinflammatory molecules and its capacity to promote activation of neutrophils and macrophages <xref ref-type="bibr" rid="pone.0004501-Legrand1">&#x0005b;56&#x0005d;</xref>. Lysozyme is also released by three types of granules <xref ref-type="bibr" rid="pone.0004501-Lominadze1">&#x0005b;52&#x0005d;</xref>. In addition to enzymatic lysis of bacterial cell wall, it can also kill bacteria by a non-enzymatic mechanisms <xref ref-type="bibr" rid="pone.0004501-Laible1">&#x0005b;57&#x0005d;</xref>. Neutrophil gelatinase associated lipocalin (NGAL) was found in specific granules of neutrophils <xref ref-type="bibr" rid="pone.0004501-Kjeldsen1">&#x0005b;58&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Triebel1">&#x0005b;59&#x0005d;</xref>. It is involved in the allosteric activation of matrix-metalloproteinase (MMP)-9 and protection from degradation. It may function as an effector molecule of innate immune system <xref ref-type="bibr" rid="pone.0004501-Kjeldsen1">&#x0005b;58&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Bu1">&#x0005b;60&#x0005d;</xref>.</p><p>Proteins S100-A8 and A9, two Ca<sup>2&#x0002b;</sup>-binding proteins of the S100 family are secreted from neutrophils by the three types of granules as a heterodimeric complex (S100-A8/S100-A9) <xref ref-type="bibr" rid="pone.0004501-Andersson1">&#x0005b;61&#x0005d;</xref>&#x02013;<xref ref-type="bibr" rid="pone.0004501-Odink1">&#x0005b;63&#x0005d;</xref>. High levels of the proteins have been found in the extra-cellular milieu during inflammatory conditions <xref ref-type="bibr" rid="pone.0004501-Nacken1">&#x0005b;64&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Roth1">&#x0005b;65&#x0005d;</xref>. The S100-A8/A9 heterodimer is an antimicrobial complex that exhibits cytokine-like functions in the inflammatory sites <italic>via</italic> activation of NFkappa B and p38MAPK <xref ref-type="bibr" rid="pone.0004501-Sunahori1">&#x0005b;66&#x0005d;</xref>. Hsp70, an ubiquitous family of protein chaperones that assist in folding of newly synthesized peptides and translocation of proteins across biological membranes, plays regulatory roles in signal transduction, cell cycle and apoptosis <xref ref-type="bibr" rid="pone.0004501-Kang1">&#x0005b;67&#x0005d;</xref>. Hsp70 is known to contribute to the mechanisms of cell protection against a variety of stress and cytotoxic factors, providing an increase of cell survival <xref ref-type="bibr" rid="pone.0004501-Lasunskaia1">&#x0005b;68&#x0005d;</xref>. Leukotriene A-4 hydrolase is released by the specific granules of neutrophils. It catalyzes the final and commited step in the biosynthesis of leukotriene B4, a potent chemotactic agent for neutrophils, eosinophils, monocyted and T cells that play key roles in the innate immune response <xref ref-type="bibr" rid="pone.0004501-Goodarzi1">&#x0005b;69&#x0005d;</xref>.</p><p>A considerable number of studies have demonstrated that the neuroendocrine and immune systems communicate to promote reciprocal regulation in the host. Not only may immune cells sense pathogens and secrete proteins that modify cells of the neuroendocrine system but factors secreted by the neuroendocrine system may also bring about changes in immune cell activity <xref ref-type="bibr" rid="pone.0004501-Sternberg1">&#x0005b;26&#x0005d;</xref>.</p><p>In addition to CAT, substance P is another neuro-immunomodulator that may inhibit nicotinic cholinergic-stimulated catecholamine release, but displays a lower potency <xref ref-type="bibr" rid="pone.0004501-Cheung1">&#x0005b;70&#x0005d;</xref>. PACAP displays numerous functions in cells of neuronal and non neuronal origin and functional VIP/PACAP receptors have been demonstrated on PMNs, mediating Ca<sup>2&#x0002b;</sup>- dependent pro-inflammatory activities through the activation of multiple regulatory pathways <xref ref-type="bibr" rid="pone.0004501-Vaudry1">&#x0005b;71&#x0005d;</xref>. Thus, it was demonstrated that the extracellular and intracellular Ca<sup>2&#x0002b;</sup> play key roles in PACAP mediated proinflammatory activities <xref ref-type="bibr" rid="pone.0004501-Harfi1">&#x0005b;72&#x0005d;</xref>. In addition, it has been reported that, in contrast to the inhibitory effect of CAT, PACAP may induce an increase of Ca<sup>2&#x0002b;</sup> entry and catecholamine release in bovine chromaffin cells by a a unique pathway distinct from nAChR, VOCs and SOCs <xref ref-type="bibr" rid="pone.0004501-Morita1">&#x0005b;73&#x0005d;</xref>. Hence, in contrast to the action of PACAP, CAT may control the proinflammatory activity <italic>via</italic> a retroactive loop, inhibiting the adrenal medulla by an autocrine mechanism while enhancing PMNs secretions of a range of immunoactive factors.</p><p>To conclude, the data reported here are important for our understanding of the role for CgA in innate immunity and for its crucial role as a mediator in the cross-talk between the neuroendocrine and immune systems. All together, the immunomodulatory activities of CHR and CAT may be important for the design of pharmacological strategies to maintain homeostasis during recruitment of PMNs in microbial and systemic infections.</p></sec><sec sec-type="materials|methods" id="s4"><title>Materials and Methods</title><sec id="s4a"><title>Peptide synthesis</title><p>All the synthetic peptides were prepared on an Applied Biosystems 433A peptide synthesizer (Foster City, USA), using the stepwise solid-phase approach with 9-fluorenylmethoxycarbonyl (Fmoc) chemistry. Then, the synthetic peptides were purified by RP-HPLC on a Macherey Nagel Nucleosil RP 300-7C18 column (10&#x000d7;250 mm; particle size 7 &#x000b5;m and pore size 100 nm). Rhodamine fluorophore 5(6)-carboxytetramethyl rhodamine was conjugated with peptides at the N-terminal extremity, as previously described <xref ref-type="bibr" rid="pone.0004501-Lugardon2">&#x0005b;24&#x0005d;</xref>. Synthetic peptides were analysed by mass spectrometry and automated Edman sequencing on an Applied Sequencing System (Applied Biosystems, Foster City, USA) <xref ref-type="bibr" rid="pone.0004501-MetzBoutigue1">&#x0005b;5&#x0005d;</xref>. MALDI mass measurements were carried out on an Ultraflex&#x02122; TOF/TOF (Bruker Daltonics, USA) to perform a rapid control of synthetic peptides according to the procedure previously reported <xref ref-type="bibr" rid="pone.0004501-Gevaert1">&#x0005b;74&#x0005d;</xref>.</p></sec><sec id="s4b"><title>Cells and flow cytometry measurements</title><p>Human PMNs were prepared from buffy coats purchased at the Etablissement Fran&#x000e7;ais du Sang &#x02013; Strasbourg, France from anonymous and healthy donors from either sex. Briefly, 40 mL of a 1/3 (vol/vol) dilution of blood cells in 0.9&#x00025; (wt/vol) NaCl was layered on 12 mL of 15 J Prep (Techgen International, Voisins le Bretonneux, France). After centrifugation at 800&#x000d7; <italic>g</italic> for 20 min, the pellet was suspended in 30 mL of 0.9&#x00025; NaCl, added to 10 mL of 6&#x00025; (wt/vol) dextran, and sedimented for 30 min. Thirty mL of the supernatant was centrifuged for 10 min at 800&#x000d7; <italic>g</italic>. The pellet was suspended in Hepes buffer (140 mM NaCl, 5 mM KCl, 10 mM glucose, 0.1 mM EGTA, 10 mM Hepes, 3 mM Tris; pH 7.3) and the contaminating erythrocytes were removed by hypotonic lysis for 45 s and subsequent washing in Hepes buffer <xref ref-type="bibr" rid="pone.0004501-Colin1">&#x0005b;75&#x0005d;</xref>. The final suspension was adjusted to a concentration of 6.10<sup>6</sup> PMNs/mL and 0.1&#x00025; (Wt/vol) bovine serum albumin was added to prevent non-specific leucotoxin adherence on tube walls.</p><p>To flow cytometry measurements PMNs were suspended at a concentration of 5.10<sup>5</sup> cells/mL in Hepes and measurements from 3000 PMNs were carried out using a FacSort&#x000ae; flow cytometer (Becton-Dickinson, Le Pont de Claix, France) equipped with a 15 mW argon laser tuned to 488 nm <xref ref-type="bibr" rid="pone.0004501-Meunier1">&#x0005b;76&#x0005d;</xref>.</p><p>We evaluated the intracellular calcium, using flow cytometry of cells previously loaded with 5 &#x000b5;M Fluo-3 (Molecular Probes, New Brunswick, USA). The increase of Fluo-3 fluorescence was measured with different CgA-derived peptides in absence or after addition of 1.1 mM extracellular CaCl<sub>2</sub><xref ref-type="bibr" rid="pone.0004501-BabaMoussa1">&#x0005b;77&#x0005d;</xref>. Fluo-3 fluorescence was measured from the fluorescence light 1 (FL1: &#x003bb;<sub>Em</sub>&#x0200a;&#x0003d;&#x0200a;530 nm) using Cell Quest Pro&#x02122; software (Becton-Dickinson, Le Pont de Claix, France). Data provided are the average of three independent experiments of different cell preparations. Mean variations, mainly never exceed 10&#x00025; of the measured values.</p></sec><sec id="s4c"><title>Time-lapse intracellular Ca<sup>2&#x0002b;</sup> imaging</title><p>PMNs were incubated for 30 min at 37&#x000b0;C in Hepes-buffered Krebs medium (130 mM NaCl, 4.5 mM KCl, 1.2 mM MgSO<sub>4</sub>, 2.5 mM CaCl<sub>2</sub>, 11 mM D-glucose, 10 mM Hepes, pH 7.4) with 2 &#x000b5;M Fura-2-AM. Cells were then washed with Hepes-buffered Krebs medium and subsequently incubated for 20 min to allow Fura-2-AM hydrolysis. After three additional washes the cells were placed on an inverted microscope (Axiovert 35M Zeiss, Germany), superfused with Krebs solution (1 mL/min), and alternatively illuminated at 350&#x000b1;10 nm and 380&#x000b1;10 nm. The fluorescent emission was observed using a long pass filter at 510 nm. For each excitation wavelength and every 2 s an image pair was recorded using a CCD camera (ImageEM&#x02122;, Hamamatsu Photonics, Hamamatsu, Japan) and fluorescence ratio images were calculated subsequently using Metafluor&#x02122; software (Molecular Devices, Downingtown, USA).</p></sec><sec id="s4d"><title>Spectrofluorometry determination</title><p>PMNs were loaded with Fura-2 as above and washed in EGTA buffer with 1.1 mM CaCl<sub>2</sub> added. Continuous variations of fluorescence intensities were recorded using a dual excitation and dual emission spectrofluorometer Deltascan (Bioritek, PTI, Chamarande, France) with slits set at 4 nm. One mL of PMNs (4.10<sup>6</sup> cells/mL) was added to 1 mL of the assay solution under constant stirring in a 4 ml cuve (1 cm light path) thermostated at 37&#x000b0;C. Wavelengths were settled at 340 nm (Ca <sup>2&#x0002b;</sup>) and 360 nm (Mn<sup>2&#x0002b;</sup>) for excitation, and 510 nm for emission. Data were expressed in arbitrary units.</p></sec><sec id="s4e"><title>Confocal microscopy analysis of rhodamine-labelled peptide loaded PMNs</title><p>PMNs (1.10<sup>6</sup>/mL) were incubated 2 min at room temperature (RT) with rhodamine-labelled peptides (20 &#x000b5;M) in Phosphate Buffered Saline consisting of 10.5 mM KH<sub>2</sub>PO<sub>4,</sub> 30 mM Na<sub>2</sub>HPO<sub>4</sub>, 0.154 M NaCl, pH 7.4, washed and subsequently centrifuged by cytospins of 1&#x02013;2.10<sup>5</sup> isolated PMNs onto glass slides (300 rpm, 10 min, RT). Cytospins were fixed with 4&#x00025; (v/v) paraformaldehyde in PBS at RT for 20 min, then incubated with Draq-5 (dilution1&#x02236;500, Biostatus Limited., Leicestershire, UK) for 15 min. Stained cells were monitored with a Zeiss LSM 510 laser scanning microscope (Zeiss, Iena, Germany) equipped with a Planapo oil immersion objective (&#x000d7;63, numerical aperture 1.4).</p></sec><sec id="s4f"><title>Surface Plasmon Resonance experiments</title><p>Experiments were conducted on a Biacore 3000&#x02122; (GE Healthcare) and peptides were immobilized on a CM5 Biacore chip using amine-coupling <xref ref-type="bibr" rid="pone.0004501-Jonsson1">&#x0005b;78&#x0005d;</xref>. The surface of the chip was activated for 7 min at a flow rate of 5 &#x000b5;L/min with a mixture of 50 mM NHS and 0.2 mM EDC. Peptides were covalently linked to the surface giving up to 2000 resonance units (RU). Ethanolamine (1M, pH8.5) was injected for 7 min to block the remaining activated groups. 5 &#x000b5;M CaM (Sigma, St. Louis, MO, USA) addition was performed at an injection flow of 20 &#x000b5;L/min in 50 mM NaCl, 2 mM CaCl<sub>2</sub>, 20 mM Tris pH6.5 until stabilization was reached (10 min). Dissociation was registered for 10 min after the end of injections. All measurements were performed at 20&#x000b0;C. Sensorgrams were analyzed by using BIAevaluation Software.</p></sec><sec id="s4g"><title>Calmodulin-Affinity Chromatography and dotblot immunodetection</title><p>CHR and CAT were prepared in buffer A (50 mM NaCl, 2 mM CaCl2, 50 mM Tris-HCl, pH 7.5) and loaded on 0.1 ml CaM-Sepharose 4B column (GE healthcare, Buckinghamshire, United Kingdom) with molar ratio 10&#x02236;1. The mixtures were incubated at room temperature for 1 h. Afterwards, the column was washed (x5) with 1 mL of buffer A, and (x3) 0.1mL buffer B (50 mM NaCl and 2 mM EGTA, 50 mM Tris-HCl, pH 7.5) were used to elute the CaM binding peptides. The elutions were analyzed by dotblot onto PVDF membrane with pore 0.2 &#x000b5;M (Millepore, Billerica, MA, USA) with specific antibodies anti-CHR (monoclonal anti-CGA<sub>47&#x02013;68</sub> (dilution 1&#x02236;5,000) and anti-CAT (anti-CGA<sub>344&#x02013;364</sub> (dilution 1&#x02236;20,000) <xref ref-type="bibr" rid="pone.0004501-Briolat1">&#x0005b;17&#x0005d;</xref>, <xref ref-type="bibr" rid="pone.0004501-Lugardon2">&#x0005b;24&#x0005d;</xref>. Immunoreactivity signals were developed using goat anti-mouse IgG conjugated to peroxidase (dilution 1&#x02236;400,000, Jackson Immunoresearch laboratories, Baltimore Pike, USA).</p></sec><sec id="s4h"><title>Immunocytochemistry of iPLA2 in PMNs</title><p>Cytospins were prepared by centrifugation of 1&#x02013;2.10<sup>5</sup> isolated PMNs onto glass slides (300 rpm, 10 min), then fixed with 4&#x00025; (v/v) paraformaldehyde in PBS, at RT for 20 min, permeabilized with PBS containing 1&#x00025; (v/v) Triton X-100 (Sigma, St. Louis, USA) at RT for 30 min, and blocked by incubation in PBS containing 0.25&#x00025; (w/v) bovine serum albumin. Subsequently, cytospins were incubated with primary antibodies anti-iPLA<sub>2</sub> polyclonal antibody (dilution 1&#x02236;100, Cayman chemical, Ann Arbor, USA) for 1 h at 37&#x000b0;C. Cytospins were washed with PBS, then incubated with secondary antibodies Alexa 488-conjugated donkey anti-rabbit IgG (dilution 1&#x02236;2000, Molecular Probes, Carlsbad, USA) during 45 min at 37&#x000b0;C, finally incubated with Draq-5 (dilution 1&#x02236;500) for 15 min. Immunofluorescence staining was monitored with a Zeiss LSM 510 laser scanning microscope equipped with a Planapo oil immersion objective (&#x000d7;63, numerical aperture 1.4).</p></sec><sec id="s4i"><title>Detection of iPLA<sub>2</sub> in PMNs and iPLA<sub>2</sub> activity assay</title><sec id="s4i1"><title>Subcellular fractionation of PMNs</title><p>PMNs (5.10<sup>7</sup>/mL) were sonicated (10 W) in the absence or presence of 1&#x00025; (v/v) Triton X-100, in the buffer 1 mM phenylmethysulphonyl fluoride, 1 mM EDTA, 50 mM Tris-HCl pH 7.5 for 3 times of 10 s with 15 s break between cycles, then spun down at 10,000&#x000d7; <italic>g</italic> for 15 min at 4&#x000b0;C. The pellet containing membranes was collected and the supernatant was further centrifuged at 100,000&#x000d7; g for 60 min at 4&#x000b0;C <xref ref-type="bibr" rid="pone.0004501-Csutora1">&#x0005b;44&#x0005d;</xref>. The amount of proteins contained in membrane and cytoplasm fractions was determined by Bradford method, and both preparations were stored at &#x02212;20&#x000b0;C for later use.</p></sec><sec id="s4i2"><title>Gel electrophoresis and Western-blot analysis of iPLA<sub>2</sub> in PMNs</title><p>Fifty &#x000b5;g proteins of each sample were separated on 12&#x00025; sodium dodecyl sulfate-polyacrylamide gel electrophoresis SDS-PAGE gradient gels (SDS-PAGE) and electrotransferred onto polyvinyldifluorene membranes (GE Healthcare Bioscience). IPLA<sub>2</sub> were detected with a polyclonal anti-iPLA<sub>2</sub> (dilution1&#x02236;500, Cayman Chemicals, Ann Arbor, MI, USA), and signal was developed using goat anti-rabbit IgG conjugated to peroxidase (dilution 1&#x02236;50,000, Jackson Immunoresearch Laboratories, Baltimore Pike, USA) to determine immunoreactivity <xref ref-type="bibr" rid="pone.0004501-Muller1">&#x0005b;79&#x0005d;</xref>.</p></sec><sec id="s4i3"><title>iPLA<sub>2</sub> activity assay</title><p>PMNs (3.10<sup>8</sup>) were collected, sonicated 3 times for 10 s with a 15 s break between cycles, and centrifuged at 15,000&#x000d7; <italic>g</italic> for 20 min at 4&#x000b0;C. The supernatant was removed and kept on ice. After determination of the protein concentration (Bradford assay), iPLA<sub>2</sub> activity measurement was obtained in presence of different peptide concentrations using the cPLA<sub>2</sub> assay kit, according to the modified method previously reported (cPLA<sub>2</sub> assay kit, Caymen chemical), <xref ref-type="bibr" rid="pone.0004501-Smani1">&#x0005b;36&#x0005d;</xref>. Results were from two similar experiments, each performed in triplicates.</p></sec></sec><sec id="s4j"><title>Characterization of secretions obtained after stimulation of PMNs by CHR and CAT</title><sec id="s4j1"><title>Stimulation and purification</title><p>PMNs secretory products were obtained after stimulation of 1.10<sup>8</sup> PMNs with 20 &#x000b5;M CHR or 20 &#x000b5;M CAT in EGTA buffer for 20 min. PMNs were centrifuged at 800&#x000d7; <italic>g</italic> for 10 min at 4&#x000b0;C and the supernatant was recovered. Desalting and elimination of low molecular weights protein were achieved by centrifugation with a molecular cut-off 3 kDa Centricon (Pall, New York, USA), then the material was stored at &#x02212;20&#x000b0;C for further analyses.</p><p>PMNs secretions induced by CHR and CAT were purified using a DIONEX Dual Gradient system (Dionex, Sunnyvale, USA) and a Nucleosil RP300&#x02013;5C18 column (4&#x000d7;250 mm, 5 &#x000b5;m particle size, 300-&#x000c5; porosity; Macherey-Nagel, Hoerdt, France). Absorbance was monitored at 214 nm, and the solvent system consisted of 0.1&#x00025; (v/v) trifluoroacetic acid in water (solvent A) and 0.1&#x00025; (v/v) trifluoroacetic acid in 70&#x00025; (v/v) acetonitrile-water (solvent B with a flow rate of 1 mL/min. Gradient was indicated on chromatograms and fractions of 700 &#x000b5;L were collected.</p></sec><sec id="s4j2"><title>Mass spectrometry analysis</title><p>The cysteine residues from the RP-HPLC fractions were reduced by 50 &#x000b5;L of 10 mM dithiothreitol at 57&#x000b0;C and alkylated by 50 &#x000b5;Lof 55 mM iodoacetamide. The proteins were digested with 40 &#x000b5;L of 12.5 ng/&#x000b5;L of modified porcine trypsin (Promega, Madison, WI, USA) in 25 mM NH<sub>4</sub>HCO<sub>3</sub> at 37&#x000b0;C for 14 h.</p><p>The generated peptides were analyzed directly by NanoLC-MS/MS on an Agilent 1100 Series HPLC-Chip/MS system (Agilent Technologies, Palo Alto, USA) coupled to an HCT Ultra ion trap (Bruker Daltonics, Bremen, Germany). The chip contained a Zorbax 300SB-C18 (43 mm&#x000d7;75 &#x000b5;m, with a 5 &#x000b5;m particle size) column and a Zorbax 300SB-C18 (40 nL, 5 &#x000b5;m) enrichment column. The solvent system consisted of 2&#x00025; (v/v) acetonitrile, 0.1&#x00025; (v/v) formic acid in water (solvent A) and 2&#x00025; (v/v) water, 0.1&#x00025; formic acid in acetonitrile (solvent B). The sample was loaded into the enrichment column at a flow rate set to 3.75 &#x000b5;L/min with solvent A. Elution was performed at a flow rate of 300 nL/min with a 8&#x02013;40&#x00025; linear gradient (solvent B) over 12 min and followed by a 70&#x00025; stage (solvent B) over 5 min before the reconditioning of the column at 92&#x00025; of solvent A. The complete system was fully controlled by ChemStation Rev. B.01.03 (Agilent Technologies).</p><p>All the analyses were performed using an HCT&#x0002b; ion trap (Bruker Daltonics, Bremen Germany). The peptides were ionised by positive electrospray and fragmented by CID. The trap was externally calibrated with tunning mix for LC/MSD ion trap G2431A (Agilent Technologies). The voltage applied to the capillary cap was optimized to &#x02212;1750 V. The MS scanning was performed in the standard enhanced resolution mode at a scan rate of 8.100 m/z per second. The mass range was 250 to 2500 m/z. The Ion Charge Control was 100000 and the maximum accumulation time was 200 ms. A total of 4 scans were averaged to obtain a MS spectrum and the rolling average was 2.</p><p>For tandem MS experiments, the system was operated with automatic switching between MS and MS/MS modes. The 3 most abundant peptides with an isolation width of 4 m/z, preferring doubly charged ions (absolute threshold of 2000 and a relative of 5&#x00025;) were selected on each MS spectrum for further isolation and fragmentation. Ions were excluded after 2 spectra and released after 1 min.</p><p>Smart Parameters Setting was used for selected precursor ions. The MS/MS scanning was performed in the ultrascan resolution mode at a scan rate of 26.000 m/z per second. The mass range was 50 to 2800 m/z. The Ion Charge Control was 300000. A total of 6 scans were averaged to obtain a MS/MS spectrum. The values 30&#x00025; and 200&#x00025; give a start and end for fragmentation relative to the fragmentation amplitude selected (1.5 V).</p><p>The complete system was fully controlled by EsquireControl 6.1 Build 90 (Bruker Daltonics) software. Mass data collected during analysis were processed, converted into .mgf files using DataAnalysis 3.4 Build 179 (Bruker Daltonics) software. The standard parameters were used.</p><p>The smoothing algorithm was Savitzky Golay with a smoothing width of 0.2 m/z in 1 cycle. 250 compounds were selected with a threshold of 60000. The algorithm &#x0201c;Accu Mass&#x0201d; was used.</p><p>The MS and the MS/MS data were searched using a local Mascot server (version MASCOT 2. 2.0, MatrixScience, UK). Searches were performed with a mass tolerance of 200 ppm in MS mode and 0.3 Da in MS/MS mode and with the following parameters: trypsin specificity, one missed cleavage, cysteine carbamidomethylation and methionine oxidation (and protein amino-terminal acetylation) as variable modifications, trap fragmentation, without constraining protein molecular weight or isoelectric point and without any taxonomic restriction.</p><p>To minimize false positive identifications, the results were subjected to very stringent filtering criteria. For the identification of a protein with two peptides or more, at least two unique peptides had to a Mascot ion score above 20. In the case of single peptide hits, the score of the unique peptide must be greater than the 52. For the estimation of the false positive rate, a target-decoy database search was performed <xref ref-type="bibr" rid="pone.0004501-Elias1">&#x0005b;80&#x0005d;</xref>. In this approach, peptides are matched against a database consisting of the native protein sequences found in the database (target) and of the sequence-reversed entries (decoy). The evaluations were performed using the peptide validation software Scaffold (Proteome Software, Portland, USA). This strategy was used to obtain a final catalogue of proteins with an estimated false positive rate below 1&#x00025;.</p></sec></sec><sec id="s4k"><title>Drugs</title><p>Bromoenol Lactone (BEL), Thapsigargin (TG), Calmidazolium (CMZ), Bromophenacyl bromide (BPB), 2-Aminoethyl diphenylborinate (2-APB), N-6-aminohexyl-5-chloro-l-naphthalenesulfonamide (W7), Arachidonic acid (AA) and Rhodamine fluorophore, 5(6)-carboxytetramethyl rhodamine were purchased from Sigma (St. Louis, MO, USA).</p></sec><sec id="s4l"><title>Statistical analysis</title><p>Group data are presented as mean&#x000b1;SD (as specified in the text and figure legends). Student's t test was used to determine the significance of data (&#x0002a;), <italic>p</italic>&#x0003c;0.05.</p></sec></sec><sec sec-type="supplementary-material" id="s5"><title>Supporting Information</title><supplementary-material content-type="local-data" id="pone.0004501.s001"><label>Figure S1</label><caption><p>(0.30 MB XLS)</p></caption><media xlink:href="pone.0004501.s001.xls" mimetype="application" mime-subtype="vnd.ms-excel"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material><supplementary-material content-type="local-data" id="pone.0004501.s002"><label>Figure S2</label><caption><p>(0.41 MB PDF)</p></caption><media xlink:href="pone.0004501.s002.pdf" mimetype="application" mime-subtype="pdf"><caption><p>Click here for additional data file.</p></caption></media></supplementary-material></sec></body><back><ack><p>We are grateful to Raymonde Girardot (EA 3432, Facult&#x000e9; de M&#x000e9;decine, Strasbourg) for expert technical assistance in neutrophils preparation and flow cytometry measurements. We thank Bernard Gu&#x000e9;rold (Inserm U575, Strasbourg) for his excellent technical expertise in peptide synthesis.</p></ack><ref-list><title>References</title><ref id="pone.0004501-Helle1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Helle</surname><given-names>KB</given-names></name><name><surname>Corti</surname><given-names>A</given-names></name><name><surname>Metz-Boutigue</surname><given-names>MH</given-names></name><name><surname>Tota</surname><given-names>B</given-names></name></person-group><year>2007</year><article-title>The endocrine role for chromogranin A: a prohormone for peptides with regulatory properties.</article-title><source>Cell Mol Life Sci</source><volume>64</volume><fpage>2863</fpage><lpage>2886</lpage><pub-id pub-id-type="pmid">17717629</pub-id></citation></ref><ref id="pone.0004501-Tatemoto1"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tatemoto</surname><given-names>K</given-names></name><name><surname>Efendic</surname><given-names>S</given-names></name><name><surname>Mutt</surname><given-names>V</given-names></name><name><surname>Makk</surname><given-names>G</given-names></name><name><surname>Feistner</surname><given-names>GJ</given-names></name><etal/></person-group><year>1986</year><article-title>Pancreastatin, a novel pancreatic peptide that inhibits insulin secretion.</article-title><source>Nature</source><volume>324</volume><fpage>476</fpage><lpage>478</lpage><pub-id pub-id-type="pmid">3537810</pub-id></citation></ref><ref id="pone.0004501-Eiden1"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Eiden</surname><given-names>LE</given-names></name></person-group><year>1987</year><article-title>Is chromogranin a prohormone?</article-title><source>Nature</source><volume>325</volume><fpage>301</fpage><pub-id pub-id-type="pmid">3808024</pub-id></citation></ref><ref id="pone.0004501-Seidah1"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Seidah</surname><given-names>NG</given-names></name><name><surname>Chretien</surname><given-names>M</given-names></name></person-group><year>1999</year><article-title>Proprotein and prohormone convertases: a family of subtilases generating diverse bioactive polypeptides.</article-title><source>Brain Res</source><volume>848</volume><fpage>45</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">10701998</pub-id></citation></ref><ref id="pone.0004501-MetzBoutigue1"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metz-Boutigue</surname><given-names>MH</given-names></name><name><surname>Garcia-Sablone</surname><given-names>P</given-names></name><name><surname>Hogue-Angeletti</surname><given-names>R</given-names></name><name><surname>Aunis</surname><given-names>D</given-names></name></person-group><year>1993</year><article-title>Intracellular and extracellular processing of chromogranin A.</article-title><source>Determination of cleavage sites, Eur J Biochem</source><volume>217</volume><fpage>247</fpage><lpage>257</lpage></citation></ref><ref id="pone.0004501-Koeslag1"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koeslag</surname><given-names>JH</given-names></name><name><surname>Saunders</surname><given-names>PT</given-names></name><name><surname>Wessels</surname><given-names>JA</given-names></name></person-group><year>1999</year><article-title>The chromogranins and the counter-regulatory hormones: do they make homeostatic sense?</article-title><source>J Physiol</source><volume>517 (Pt 3)</volume><fpage>643</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">10358106</pub-id></citation></ref><ref id="pone.0004501-Aardal1"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Aardal</surname><given-names>S</given-names></name><name><surname>Helle</surname><given-names>KB</given-names></name></person-group><year>1992</year><article-title>The vasoinhibitory activity of bovine chromogranin A fragment (vasostatin) and its independence of extracellular calcium in isolated segments of human blood vessels.</article-title><source>Regul Pept</source><volume>41</volume><fpage>9</fpage><lpage>18</lpage><pub-id pub-id-type="pmid">1455014</pub-id></citation></ref><ref id="pone.0004501-Brekke1"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Brekke</surname><given-names>JF</given-names></name><name><surname>Osol</surname><given-names>GJ</given-names></name><name><surname>Helle</surname><given-names>KB</given-names></name></person-group><year>2002</year><article-title>N-terminal chromogranin-derived peptides as dilators of bovine coronary resistance arteries.</article-title><source>Regul Pept</source><volume>105</volume><fpage>93</fpage><lpage>100</lpage><pub-id pub-id-type="pmid">11891009</pub-id></citation></ref><ref id="pone.0004501-Cerra1"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cerra</surname><given-names>MC</given-names></name><name><surname>Gallo</surname><given-names>MP</given-names></name><name><surname>Angelone</surname><given-names>T</given-names></name><name><surname>Quintieri</surname><given-names>AM</given-names></name><name><surname>Pulera</surname><given-names>E</given-names></name><etal/></person-group><year>2008</year><article-title>The homologous rat chromogranin A1-64 (rCGA1-64) modulates myocardial and coronary function in rat heart to counteract adrenergic stimulation indirectly via endothelium-derived nitric oxide.</article-title><source>Faseb J</source><volume>22</volume><fpage>3992</fpage><lpage>4004</lpage><pub-id pub-id-type="pmid">18697842</pub-id></citation></ref><ref id="pone.0004501-Corti1"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Corti</surname><given-names>A</given-names></name><name><surname>Mannarino</surname><given-names>C</given-names></name><name><surname>Mazza</surname><given-names>R</given-names></name><name><surname>Angelone</surname><given-names>T</given-names></name><name><surname>Longhi</surname><given-names>R</given-names></name><etal/></person-group><year>2004</year><article-title>Chromogranin A N-terminal fragments vasostatin-1 and the synthetic CGA 7-57 peptide act as cardiostatins on the isolated working frog heart.</article-title><source>Gen Comp Endocrinol</source><volume>136</volume><fpage>217</fpage><lpage>224</lpage><pub-id pub-id-type="pmid">15028525</pub-id></citation></ref><ref id="pone.0004501-Tota1"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Tota</surname><given-names>B</given-names></name><name><surname>Mazza</surname><given-names>R</given-names></name><name><surname>Angelone</surname><given-names>T</given-names></name><name><surname>Nullans</surname><given-names>G</given-names></name><name><surname>Metz-Boutigue</surname><given-names>MH</given-names></name><etal/></person-group><year>2003</year><article-title>Peptides from the N-terminal domain of chromogranin A (vasostatins) exert negative inotropic effects in the isolated frog heart.</article-title><source>Regul Pept</source><volume>114</volume><fpage>123</fpage><lpage>130</lpage><pub-id pub-id-type="pmid">12832100</pub-id></citation></ref><ref id="pone.0004501-Blois1"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blois</surname><given-names>A</given-names></name><name><surname>Srebro</surname><given-names>B</given-names></name><name><surname>Mandala</surname><given-names>M</given-names></name><name><surname>Corti</surname><given-names>A</given-names></name><name><surname>Helle</surname><given-names>KB</given-names></name><etal/></person-group><year>2006</year><article-title>The chromogranin A peptide vasostatin-I inhibits gap formation and signal transduction mediated by inflammatory agents in cultured bovine pulmonary and coronary arterial endothelial cells.</article-title><source>Regul Pept</source><volume>135</volume><fpage>78</fpage><lpage>84</lpage><pub-id pub-id-type="pmid">16725215</pub-id></citation></ref><ref id="pone.0004501-Ferrero1"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ferrero</surname><given-names>E</given-names></name><name><surname>Scabini</surname><given-names>S</given-names></name><name><surname>Magni</surname><given-names>E</given-names></name><name><surname>Foglieni</surname><given-names>C</given-names></name><name><surname>Belloni</surname><given-names>D</given-names></name><etal/></person-group><year>2004</year><article-title>Chromogranin A protects vessels against tumor necrosis factor alpha-induced vascular leakage.</article-title><source>Faseb J</source><volume>18</volume><fpage>554</fpage><lpage>556</lpage><pub-id pub-id-type="pmid">14734634</pub-id></citation></ref><ref id="pone.0004501-Gasparri1"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gasparri</surname><given-names>A</given-names></name><name><surname>Sidoli</surname><given-names>A</given-names></name><name><surname>Sanchez</surname><given-names>LP</given-names></name><name><surname>Longhi</surname><given-names>R</given-names></name><name><surname>Siccardi</surname><given-names>AG</given-names></name><etal/></person-group><year>1997</year><article-title>Chromogranin A fragments modulate cell adhesion.</article-title><source>Identification and characterization of a pro-adhesive domain, J Biol Chem</source><volume>272</volume><fpage>20835</fpage><lpage>20843</lpage></citation></ref><ref id="pone.0004501-Amato1"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Amato</surname><given-names>A</given-names></name><name><surname>Corti</surname><given-names>A</given-names></name><name><surname>Serio</surname><given-names>R</given-names></name><name><surname>Mule</surname><given-names>F</given-names></name></person-group><year>2005</year><article-title>Inhibitory influence of chromogranin A N-terminal fragment (vasostatin-1) on the spontaneous contractions of rat proximal colon.</article-title><source>Regul Pept</source><volume>130</volume><fpage>42</fpage><lpage>47</lpage><pub-id pub-id-type="pmid">15869818</pub-id></citation></ref><ref id="pone.0004501-Ghia1"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ghia</surname><given-names>JE</given-names></name><name><surname>Pradaud</surname><given-names>I</given-names></name><name><surname>Crenner</surname><given-names>F</given-names></name><name><surname>Metz-Boutigue</surname><given-names>MH</given-names></name><name><surname>Aunis</surname><given-names>D</given-names></name><etal/></person-group><year>2005</year><article-title>Effect of acetic acid or trypsin application on rat colonic motility in vitro and modulation by two synthetic fragments of chromogranin A.</article-title><source>Regul Pept</source><volume>124</volume><fpage>27</fpage><lpage>35</lpage><pub-id pub-id-type="pmid">15544838</pub-id></citation></ref><ref id="pone.0004501-Briolat1"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Briolat</surname><given-names>J</given-names></name><name><surname>Wu</surname><given-names>SD</given-names></name><name><surname>Mahata</surname><given-names>SK</given-names></name><name><surname>Gonthier</surname><given-names>B</given-names></name><name><surname>Bagnard</surname><given-names>D</given-names></name><etal/></person-group><year>2005</year><article-title>New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.</article-title><source>Cell Mol Life Sci</source><volume>62</volume><fpage>377</fpage><lpage>385</lpage><pub-id pub-id-type="pmid">15723172</pub-id></citation></ref><ref id="pone.0004501-Lugardon1"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lugardon</surname><given-names>K</given-names></name><name><surname>Raffner</surname><given-names>R</given-names></name><name><surname>Goumon</surname><given-names>Y</given-names></name><name><surname>Corti</surname><given-names>A</given-names></name><name><surname>Delmas</surname><given-names>A</given-names></name><etal/></person-group><year>2000</year><article-title>Antibacterial and antifungal activities of vasostatin-1, the N-terminal fragment of chromogranin A.</article-title><source>J Biol Chem</source><volume>275</volume><fpage>10745</fpage><lpage>10753</lpage><pub-id pub-id-type="pmid">10753865</pub-id></citation></ref><ref id="pone.0004501-MetzBoutigue2"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Metz-Boutigue</surname><given-names>MH</given-names></name><name><surname>Goumon</surname><given-names>Y</given-names></name><name><surname>Lugardon</surname><given-names>K</given-names></name><name><surname>Strub</surname><given-names>JM</given-names></name><name><surname>Aunis</surname><given-names>D</given-names></name></person-group><year>1998</year><article-title>Antibacterial peptides are present in chromaffin cell secretory granules.</article-title><source>Cell Mol Neurobiol</source><volume>18</volume><fpage>249</fpage><lpage>266</lpage><pub-id pub-id-type="pmid">9535293</pub-id></citation></ref><ref id="pone.0004501-Taupenot1"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taupenot</surname><given-names>L</given-names></name><name><surname>Harper</surname><given-names>KL</given-names></name><name><surname>O'Connor</surname><given-names>DT</given-names></name></person-group><year>2003</year><article-title>The chromogranin-secretogranin family.</article-title><source>N Engl J Med</source><volume>348</volume><fpage>1134</fpage><lpage>1149</lpage><pub-id pub-id-type="pmid">12646671</pub-id></citation></ref><ref id="pone.0004501-Zhang1"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>K</given-names></name><name><surname>Rao</surname><given-names>F</given-names></name><name><surname>Wen</surname><given-names>G</given-names></name><name><surname>Salem</surname><given-names>RM</given-names></name><name><surname>Vaingankar</surname><given-names>S</given-names></name><etal/></person-group><year>2006</year><article-title>Catecholamine storage vesicles and the metabolic syndrome: The role of the chromogranin A fragment pancreastatin.</article-title><source>Diabetes Obes Metab</source><volume>8</volume><fpage>621</fpage><lpage>633</lpage><pub-id pub-id-type="pmid">17026486</pub-id></citation></ref><ref id="pone.0004501-Goumon1"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goumon</surname><given-names>Y</given-names></name><name><surname>Strub</surname><given-names>JM</given-names></name><name><surname>Moniatte</surname><given-names>M</given-names></name><name><surname>Nullans</surname><given-names>G</given-names></name><name><surname>Poteur</surname><given-names>L</given-names></name><etal/></person-group><year>1996</year><article-title>The C-terminal bisphosphorylated proenkephalin-A-(209-237)-peptide from adrenal medullary chromaffin granules possesses antibacterial activity.</article-title><source>Eur J Biochem</source><volume>235</volume><fpage>516</fpage><lpage>525</lpage><pub-id pub-id-type="pmid">8654396</pub-id></citation></ref><ref id="pone.0004501-Kieffer1"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kieffer</surname><given-names>AE</given-names></name><name><surname>Goumon</surname><given-names>Y</given-names></name><name><surname>Ruh</surname><given-names>O</given-names></name><name><surname>Chasserot-Golaz</surname><given-names>S</given-names></name><name><surname>Nullans</surname><given-names>G</given-names></name><etal/></person-group><year>2003</year><article-title>The N- and C-terminal fragments of ubiquitin are important for the antimicrobial activities.</article-title><source>Faseb J</source><volume>17</volume><fpage>776</fpage><lpage>778</lpage><pub-id pub-id-type="pmid">12594174</pub-id></citation></ref><ref id="pone.0004501-Lugardon2"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lugardon</surname><given-names>K</given-names></name><name><surname>Chasserot-Golaz</surname><given-names>S</given-names></name><name><surname>Kieffer</surname><given-names>AE</given-names></name><name><surname>Maget-Dana</surname><given-names>R</given-names></name><name><surname>Nullans</surname><given-names>G</given-names></name><etal/></person-group><year>2001</year><article-title>Structural and biological characterization of chromofungin, the antifungal chromogranin A-(47&#x02013;66)-derived peptide.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>35875</fpage><lpage>35882</lpage><pub-id pub-id-type="pmid">11451958</pub-id></citation></ref><ref id="pone.0004501-Strub1"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Strub</surname><given-names>JM</given-names></name><name><surname>Garcia-Sablone</surname><given-names>P</given-names></name><name><surname>Lonning</surname><given-names>K</given-names></name><name><surname>Taupenot</surname><given-names>L</given-names></name><name><surname>Hubert</surname><given-names>P</given-names></name><etal/></person-group><year>1995</year><article-title>Processing of chromogranin B in bovine adrenal medulla. Identification of secretolytin, the endogenous C-terminal fragment of residues 614&#x02013;626 with antibacterial activity.</article-title><source>Eur J Biochem</source><volume>229</volume><fpage>356</fpage><lpage>368</lpage><pub-id pub-id-type="pmid">7744058</pub-id></citation></ref><ref id="pone.0004501-Sternberg1"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sternberg</surname><given-names>EM</given-names></name></person-group><year>2006</year><article-title>Neural regulation of innate immunity: a coordinated nonspecific host response to pathogens.</article-title><source>Nat Rev Immunol</source><volume>6</volume><fpage>318</fpage><lpage>328</lpage><pub-id pub-id-type="pmid">16557263</pub-id></citation></ref><ref id="pone.0004501-Genestier1"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Genestier</surname><given-names>AL</given-names></name><name><surname>Michallet</surname><given-names>MC</given-names></name><name><surname>Prevost</surname><given-names>G</given-names></name><name><surname>Bellot</surname><given-names>G</given-names></name><name><surname>Chalabreysse</surname><given-names>L</given-names></name><etal/></person-group><year>2005</year><article-title>Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.</article-title><source>J Clin Invest</source><volume>115</volume><fpage>3117</fpage><lpage>3127</lpage><pub-id pub-id-type="pmid">16276417</pub-id></citation></ref><ref id="pone.0004501-Joubert1"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Joubert</surname><given-names>O</given-names></name><name><surname>Viero</surname><given-names>G</given-names></name><name><surname>Keller</surname><given-names>D</given-names></name><name><surname>Martinez</surname><given-names>E</given-names></name><name><surname>Colin</surname><given-names>DA</given-names></name><etal/></person-group><year>2006</year><article-title>Engineered covalent leucotoxin heterodimers form functional pores: insights into S-F interactions.</article-title><source>Biochem J</source><volume>396</volume><fpage>381</fpage><lpage>389</lpage><pub-id pub-id-type="pmid">16494579</pub-id></citation></ref><ref id="pone.0004501-JeanFrancois1"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jean-Francois</surname><given-names>F</given-names></name><name><surname>Castano</surname><given-names>S</given-names></name><name><surname>Desbat</surname><given-names>B</given-names></name><name><surname>Odaert</surname><given-names>B</given-names></name><name><surname>Roux</surname><given-names>M</given-names></name><etal/></person-group><year>2008</year><article-title>Aggregation of cateslytin beta-sheets on negatively charged lipids promotes rigid membrane domains. A new mode of action for antimicrobial peptides?</article-title><source>Biochemistry</source><volume>47</volume><fpage>6394</fpage><lpage>6402</lpage><pub-id pub-id-type="pmid">18500827</pub-id></citation></ref><ref id="pone.0004501-JeanFrancois2"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jean-Francois</surname><given-names>F</given-names></name><name><surname>Elezgaray</surname><given-names>J</given-names></name><name><surname>Berson</surname><given-names>P</given-names></name><name><surname>Vacher</surname><given-names>P</given-names></name><name><surname>Dufourc</surname><given-names>EJ</given-names></name></person-group><year>2008</year><article-title>Pore formation induced by an antimicrobial peptide: electrostatic effects.</article-title><source>Biophys J</source></citation></ref><ref id="pone.0004501-JeanFrancois3"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jean-Francois</surname><given-names>F</given-names></name><name><surname>Khemtemourian</surname><given-names>L</given-names></name><name><surname>Odaert</surname><given-names>B</given-names></name><name><surname>Castano</surname><given-names>S</given-names></name><name><surname>Grelard</surname><given-names>A</given-names></name><etal/></person-group><year>2007</year><article-title>Variability in secondary structure of the antimicrobial peptide Cateslytin in powder, solution, DPC micelles and at the air-water interface.</article-title><source>Eur Biophys J</source><volume>36</volume><fpage>1019</fpage><lpage>1027</lpage><pub-id pub-id-type="pmid">17619185</pub-id></citation></ref><ref id="pone.0004501-Mahata1"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mahata</surname><given-names>SK</given-names></name><name><surname>O'Connor</surname><given-names>DT</given-names></name><name><surname>Mahata</surname><given-names>M</given-names></name><name><surname>Yoo</surname><given-names>SH</given-names></name><name><surname>Taupenot</surname><given-names>L</given-names></name><etal/></person-group><year>1997</year><article-title>Novel autocrine feedback control of catecholamine release. A discrete chromogranin a fragment is a noncompetitive nicotinic cholinergic antagonist.</article-title><source>J Clin Invest</source><volume>100</volume><fpage>1623</fpage><lpage>1633</lpage><pub-id pub-id-type="pmid">9294131</pub-id></citation></ref><ref id="pone.0004501-Balsinde1"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Balsinde</surname><given-names>J</given-names></name><name><surname>Balboa</surname><given-names>MA</given-names></name></person-group><year>2005</year><article-title>Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells.</article-title><source>Cell Signal</source><volume>17</volume><fpage>1052</fpage><lpage>1062</lpage><pub-id pub-id-type="pmid">15993747</pub-id></citation></ref><ref id="pone.0004501-Lohr1"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lohr</surname><given-names>C</given-names></name><name><surname>Deitmer</surname><given-names>JW</given-names></name></person-group><year>2006</year><article-title>Calcium signaling in invertebrate glial cells.</article-title><source>Glia</source><volume>54</volume><fpage>642</fpage><lpage>649</lpage><pub-id pub-id-type="pmid">17006892</pub-id></citation></ref><ref id="pone.0004501-Parekh1"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Parekh</surname><given-names>AB</given-names></name><name><surname>Putney</surname><given-names>JW</given-names><suffix>Jr.</suffix></name></person-group><year>2005</year><article-title>Store-operated calcium channels.</article-title><source>Physiol Rev</source><volume>85</volume><fpage>757</fpage><lpage>810</lpage><pub-id pub-id-type="pmid">15788710</pub-id></citation></ref><ref id="pone.0004501-Smani1"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smani</surname><given-names>T</given-names></name><name><surname>Zakharov</surname><given-names>SI</given-names></name><name><surname>Csutora</surname><given-names>P</given-names></name><name><surname>Leno</surname><given-names>E</given-names></name><name><surname>Trepakova</surname><given-names>ES</given-names></name><etal/></person-group><year>2004</year><article-title>A novel mechanism for the store-operated calcium influx pathway.</article-title><source>Nat Cell Biol</source><volume>6</volume><fpage>113</fpage><lpage>120</lpage><pub-id pub-id-type="pmid">14730314</pub-id></citation></ref><ref id="pone.0004501-Smani2"><label>37</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Smani</surname><given-names>T</given-names></name><name><surname>Zakharov</surname><given-names>SI</given-names></name><name><surname>Leno</surname><given-names>E</given-names></name><name><surname>Csutora</surname><given-names>P</given-names></name><name><surname>Trepakova</surname><given-names>ES</given-names></name><etal/></person-group><year>2003</year><article-title>Ca2&#x0002b;-independent phospholipase A2 is a novel determinant of store-operated Ca2&#x0002b; entry.</article-title><source>J Biol Chem</source><volume>278</volume><fpage>11909</fpage><lpage>11915</lpage><pub-id pub-id-type="pmid">12547829</pub-id></citation></ref><ref id="pone.0004501-Itagaki1"><label>38</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Itagaki</surname><given-names>K</given-names></name><name><surname>Kannan</surname><given-names>KB</given-names></name><name><surname>Livingston</surname><given-names>DH</given-names></name><name><surname>Deitch</surname><given-names>EA</given-names></name><name><surname>Fekete</surname><given-names>Z</given-names></name><etal/></person-group><year>2002</year><article-title>Store-operated calcium entry in human neutrophils reflects multiple contributions from independently regulated pathways.</article-title><source>J Immunol</source><volume>168</volume><fpage>4063</fpage><lpage>4069</lpage><pub-id pub-id-type="pmid">11937565</pub-id></citation></ref><ref id="pone.0004501-Rhoads1"><label>39</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Rhoads</surname><given-names>AR</given-names></name><name><surname>Friedberg</surname><given-names>F</given-names></name></person-group><year>1997</year><article-title>Sequence motifs for calmodulin recognition.</article-title><source>Faseb J</source><volume>11</volume><fpage>331</fpage><lpage>340</lpage><pub-id pub-id-type="pmid">9141499</pub-id></citation></ref><ref id="pone.0004501-Yoo1"><label>40</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yoo</surname><given-names>SH</given-names></name></person-group><year>1992</year><article-title>Identification of the Ca(2&#x0002b;)-dependent calmodulin-binding region of chromogranin A.</article-title><source>Biochemistry</source><volume>31</volume><fpage>6134</fpage><lpage>6140</lpage><pub-id pub-id-type="pmid">1627556</pub-id></citation></ref><ref id="pone.0004501-Jenkins1"><label>41</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jenkins</surname><given-names>CM</given-names></name><name><surname>Wolf</surname><given-names>MJ</given-names></name><name><surname>Mancuso</surname><given-names>DJ</given-names></name><name><surname>Gross</surname><given-names>RW</given-names></name></person-group><year>2001</year><article-title>Identification of the calmodulin-binding domain of recombinant calcium-independent phospholipase A2beta. implications for structure and function.</article-title><source>J Biol Chem</source><volume>276</volume><fpage>7129</fpage><lpage>7135</lpage><pub-id pub-id-type="pmid">11118454</pub-id></citation></ref><ref id="pone.0004501-Bolotina1"><label>42</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolotina</surname><given-names>VM</given-names></name></person-group><year>2004</year><article-title>Store-operated channels: diversity and activation mechanisms.</article-title><source>Sci STKE</source><volume>2004</volume><fpage>pe34</fpage><pub-id pub-id-type="pmid">15280576</pub-id></citation></ref><ref id="pone.0004501-Bolotina2"><label>43</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bolotina</surname><given-names>VM</given-names></name><name><surname>Csutora</surname><given-names>P</given-names></name></person-group><year>2005</year><article-title>CIF and other mysteries of the store-operated Ca2&#x0002b;-entry pathway,</article-title><source>Trends Biochem Sci</source><volume>30</volume><fpage>378</fpage><lpage>387</lpage><pub-id pub-id-type="pmid">15951181</pub-id></citation></ref><ref id="pone.0004501-Csutora1"><label>44</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Csutora</surname><given-names>P</given-names></name><name><surname>Zarayskiy</surname><given-names>V</given-names></name><name><surname>Peter</surname><given-names>K</given-names></name><name><surname>Monje</surname><given-names>F</given-names></name><name><surname>Smani</surname><given-names>T</given-names></name><etal/></person-group><year>2006</year><article-title>Activation mechanism for CRAC current and store-operated Ca2&#x0002b; entry: calcium influx factor and Ca2&#x0002b;-independent phospholipase A2beta-mediated pathway.</article-title><source>J Biol Chem</source><volume>281</volume><fpage>34926</fpage><lpage>34935</lpage><pub-id pub-id-type="pmid">17003039</pub-id></citation></ref><ref id="pone.0004501-Mookherjee1"><label>45</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mookherjee</surname><given-names>N</given-names></name><name><surname>Hancock</surname><given-names>RE</given-names></name></person-group><year>2007</year><article-title>Cationic host defence peptides: innate immune regulatory peptides as a novel approach for treating infections.</article-title><source>Cell Mol Life Sci</source><volume>64</volume><fpage>922</fpage><lpage>933</lpage><pub-id pub-id-type="pmid">17310278</pub-id></citation></ref><ref id="pone.0004501-Radek1"><label>46</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Radek</surname><given-names>K</given-names></name><name><surname>Gallo</surname><given-names>R</given-names></name></person-group><year>2007</year><article-title>Antimicrobial peptides: natural effectors of the innate immune system.</article-title><source>Semin Immunopathol</source><volume>29</volume><fpage>27</fpage><lpage>43</lpage><pub-id pub-id-type="pmid">17621952</pub-id></citation></ref><ref id="pone.0004501-Angeletti1"><label>47</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Angeletti</surname><given-names>RH</given-names></name><name><surname>Aardal</surname><given-names>S</given-names></name><name><surname>Serck-Hanssen</surname><given-names>G</given-names></name><name><surname>Gee</surname><given-names>P</given-names></name><name><surname>Helle</surname><given-names>KB</given-names></name></person-group><year>1994</year><article-title>Vasoinhibitory activity of synthetic peptides from the amino terminus of chromogranin A.</article-title><source>Acta Physiol Scand</source><volume>152</volume><fpage>11</fpage><lpage>19</lpage><pub-id pub-id-type="pmid">7810329</pub-id></citation></ref><ref id="pone.0004501-Russell1"><label>48</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Russell</surname><given-names>J</given-names></name><name><surname>Gee</surname><given-names>P</given-names></name><name><surname>Liu</surname><given-names>SM</given-names></name><name><surname>Angeletti</surname><given-names>RH</given-names></name></person-group><year>1994</year><article-title>Inhibition of parathyroid hormone secretion by amino-terminal chromogranin peptides.</article-title><source>Endocrinology</source><volume>135</volume><fpage>337</fpage><lpage>342</lpage><pub-id pub-id-type="pmid">8013369</pub-id></citation></ref><ref id="pone.0004501-Henriques1"><label>49</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Henriques</surname><given-names>ST</given-names></name><name><surname>Melo</surname><given-names>MN</given-names></name><name><surname>Castanho</surname><given-names>MA</given-names></name></person-group><year>2006</year><article-title>Cell-penetrating peptides and antimicrobial peptides: how different are they?</article-title><source>Biochem J</source><volume>399</volume><fpage>1</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">16956326</pub-id></citation></ref><ref id="pone.0004501-Lewis1"><label>50</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lewis</surname><given-names>RS</given-names></name></person-group><year>2007</year><article-title>The molecular choreography of a store-operated calcium channel.</article-title><source>Nature</source><volume>446</volume><fpage>284</fpage><lpage>287</lpage><pub-id pub-id-type="pmid">17361175</pub-id></citation></ref><ref id="pone.0004501-Randriamampita1"><label>51</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Randriamampita</surname><given-names>C</given-names></name><name><surname>Tsien</surname><given-names>RY</given-names></name></person-group><year>1993</year><article-title>Emptying of intracellular Ca2&#x0002b; stores releases a novel small messenger that stimulates Ca2&#x0002b; influx.</article-title><source>Nature</source><volume>364</volume><fpage>809</fpage><lpage>814</lpage><pub-id pub-id-type="pmid">8355806</pub-id></citation></ref><ref id="pone.0004501-Lominadze1"><label>52</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lominadze</surname><given-names>G</given-names></name><name><surname>Powell</surname><given-names>DW</given-names></name><name><surname>Luerman</surname><given-names>GC</given-names></name><name><surname>Link</surname><given-names>AJ</given-names></name><name><surname>Ward</surname><given-names>RA</given-names></name><etal/></person-group><year>2005</year><article-title>Proteomic analysis of human neutrophil granules.</article-title><source>Mol Cell Proteomics</source><volume>4</volume><fpage>1503</fpage><lpage>1521</lpage><pub-id pub-id-type="pmid">15985654</pub-id></citation></ref><ref id="pone.0004501-Wong1"><label>53</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wong</surname><given-names>SH</given-names></name><name><surname>Francis</surname><given-names>N</given-names></name><name><surname>Chahal</surname><given-names>H</given-names></name><name><surname>Raza</surname><given-names>K</given-names></name><name><surname>Salmon</surname><given-names>M</given-names></name><etal/></person-group><year>2009</year><article-title>Lactoferrin is a survival factor for neutrophils in rheumatoid synovial fluid.</article-title><source>Rheumatology (Oxford)</source><volume>48</volume><fpage>39</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">19029133</pub-id></citation></ref><ref id="pone.0004501-delaRosa1"><label>54</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>de la Rosa</surname><given-names>G</given-names></name><name><surname>Yang</surname><given-names>D</given-names></name><name><surname>Tewary</surname><given-names>P</given-names></name><name><surname>Varadhachary</surname><given-names>A</given-names></name><name><surname>Oppenheim</surname><given-names>JJ</given-names></name></person-group><year>2008</year><article-title>Lactoferrin acts as an alarmin to promote the recruitment and activation of APCs and antigen-specific immune responses.</article-title><source>J Immunol</source><volume>180</volume><fpage>6868</fpage><lpage>6876</lpage><pub-id pub-id-type="pmid">18453607</pub-id></citation></ref><ref id="pone.0004501-Oseas1"><label>55</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Oseas</surname><given-names>R</given-names></name><name><surname>Yang</surname><given-names>HH</given-names></name><name><surname>Baehner</surname><given-names>RL</given-names></name><name><surname>Boxer</surname><given-names>LA</given-names></name></person-group><year>1981</year><article-title>Lactoferrin: a promoter of polymorphonuclear leukocyte adhesiveness,</article-title><source>Blood</source><volume>57</volume><fpage>939</fpage><lpage>945</lpage><pub-id pub-id-type="pmid">7214024</pub-id></citation></ref><ref id="pone.0004501-Legrand1"><label>56</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Legrand</surname><given-names>D</given-names></name><name><surname>Elass</surname><given-names>E</given-names></name><name><surname>Carpentier</surname><given-names>M</given-names></name><name><surname>Mazurier</surname><given-names>J</given-names></name></person-group><year>2005</year><article-title>Lactoferrin: a modulator of immune and inflammatory responses.</article-title><source>Cell Mol Life Sci</source><volume>62</volume><fpage>2549</fpage><lpage>2559</lpage><pub-id pub-id-type="pmid">16261255</pub-id></citation></ref><ref id="pone.0004501-Laible1"><label>57</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Laible</surname><given-names>NJ</given-names></name><name><surname>Germaine</surname><given-names>GR</given-names></name></person-group><year>1985</year><article-title>Bactericidal activity of human lysozyme, muramidase-inactive lysozyme, and cationic polypeptides against Streptococcus sanguis and Streptococcus faecalis: inhibition by chitin oligosaccharides.</article-title><source>Infect Immun</source><volume>48</volume><fpage>720</fpage><lpage>728</lpage><pub-id pub-id-type="pmid">3922894</pub-id></citation></ref><ref id="pone.0004501-Kjeldsen1"><label>58</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kjeldsen</surname><given-names>L</given-names></name><name><surname>Johnsen</surname><given-names>AH</given-names></name><name><surname>Sengelov</surname><given-names>H</given-names></name><name><surname>Borregaard</surname><given-names>N</given-names></name></person-group><year>1993</year><article-title>Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.</article-title><source>J Biol Chem</source><volume>268</volume><fpage>10425</fpage><lpage>10432</lpage><pub-id pub-id-type="pmid">7683678</pub-id></citation></ref><ref id="pone.0004501-Triebel1"><label>59</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Triebel</surname><given-names>S</given-names></name><name><surname>Blaser</surname><given-names>J</given-names></name><name><surname>Reinke</surname><given-names>H</given-names></name><name><surname>Tschesche</surname><given-names>H</given-names></name></person-group><year>1992</year><article-title>A 25 kDa alpha 2-microglobulin-related protein is a component of the 125 kDa form of human gelatinase.</article-title><source>FEBS Lett</source><volume>314</volume><fpage>386</fpage><lpage>388</lpage><pub-id pub-id-type="pmid">1281792</pub-id></citation></ref><ref id="pone.0004501-Bu1"><label>60</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bu</surname><given-names>DX</given-names></name><name><surname>Hemdahl</surname><given-names>AL</given-names></name><name><surname>Gabrielsen</surname><given-names>A</given-names></name><name><surname>Fuxe</surname><given-names>J</given-names></name><name><surname>Zhu</surname><given-names>C</given-names></name><etal/></person-group><year>2006</year><article-title>Induction of neutrophil gelatinase-associated lipocalin in vascular injury via activation of nuclear factor-kappaB.</article-title><source>Am J Pathol</source><volume>169</volume><fpage>2245</fpage><lpage>2253</lpage><pub-id pub-id-type="pmid">17148685</pub-id></citation></ref><ref id="pone.0004501-Andersson1"><label>61</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Andersson</surname><given-names>KB</given-names></name><name><surname>Sletten</surname><given-names>K</given-names></name><name><surname>Berntzen</surname><given-names>HB</given-names></name><name><surname>Fagerhol</surname><given-names>MK</given-names></name><name><surname>Dale</surname><given-names>I</given-names></name><etal/></person-group><year>1988</year><article-title>Leukocyte L1 protein and the cystic fibrosis antigen.</article-title><source>Nature</source><volume>332</volume><fpage>688</fpage><pub-id pub-id-type="pmid">3357535</pub-id></citation></ref><ref id="pone.0004501-Koike1"><label>62</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Koike</surname><given-names>T</given-names></name><name><surname>Kondo</surname><given-names>K</given-names></name><name><surname>Makita</surname><given-names>T</given-names></name><name><surname>Kajiyama</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>T</given-names></name><etal/></person-group><year>1998</year><article-title>Intracellular localization of migration inhibitory factor-related protein (MRP) and detection of cell surface MRP binding sites on human leukemia cell lines.</article-title><source>J Biochem</source><volume>123</volume><fpage>1079</fpage><lpage>1087</lpage><pub-id pub-id-type="pmid">9603996</pub-id></citation></ref><ref id="pone.0004501-Odink1"><label>63</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Odink</surname><given-names>K</given-names></name><name><surname>Cerletti</surname><given-names>N</given-names></name><name><surname>Bruggen</surname><given-names>J</given-names></name><name><surname>Clerc</surname><given-names>RG</given-names></name><name><surname>Tarcsay</surname><given-names>L</given-names></name><etal/></person-group><year>1987</year><article-title>Two calcium-binding proteins in infiltrate macrophages of rheumatoid arthritis.</article-title><source>Nature</source><volume>330</volume><fpage>80</fpage><lpage>82</lpage><pub-id pub-id-type="pmid">3313057</pub-id></citation></ref><ref id="pone.0004501-Nacken1"><label>64</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Nacken</surname><given-names>W</given-names></name><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Sorg</surname><given-names>C</given-names></name><name><surname>Kerkhoff</surname><given-names>C</given-names></name></person-group><year>2003</year><article-title>S100A9/S100A8: Myeloid representatives of the S100 protein family as prominent players in innate immunity.</article-title><source>Microsc Res Tech</source><volume>60</volume><fpage>569</fpage><lpage>580</lpage><pub-id pub-id-type="pmid">12645005</pub-id></citation></ref><ref id="pone.0004501-Roth1"><label>65</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Roth</surname><given-names>J</given-names></name><name><surname>Vogl</surname><given-names>T</given-names></name><name><surname>Sorg</surname><given-names>C</given-names></name><name><surname>Sunderkotter</surname><given-names>C</given-names></name></person-group><year>2003</year><article-title>Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules.</article-title><source>Trends Immunol</source><volume>24</volume><fpage>155</fpage><lpage>158</lpage><pub-id pub-id-type="pmid">12697438</pub-id></citation></ref><ref id="pone.0004501-Sunahori1"><label>66</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sunahori</surname><given-names>K</given-names></name><name><surname>Yamamura</surname><given-names>M</given-names></name><name><surname>Yamana</surname><given-names>J</given-names></name><name><surname>Takasugi</surname><given-names>K</given-names></name><name><surname>Kawashima</surname><given-names>M</given-names></name><etal/></person-group><year>2006</year><article-title>The S100A8/A9 heterodimer amplifies proinflammatory cytokine production by macrophages via activation of nuclear factor kappa B and p38 mitogen-activated protein kinase in rheumatoid arthritis.</article-title><source>Arthritis Res Ther</source><volume>8</volume><fpage>R69</fpage><pub-id pub-id-type="pmid">16613612</pub-id></citation></ref><ref id="pone.0004501-Kang1"><label>67</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>Y</given-names></name><name><surname>Taldone</surname><given-names>T</given-names></name><name><surname>Clement</surname><given-names>CC</given-names></name><name><surname>Fewell</surname><given-names>SW</given-names></name><name><surname>Aguirre</surname><given-names>J</given-names></name><etal/></person-group><year>2008</year><article-title>Design of a fluorescence polarization assay platform for the study of human Hsp70.</article-title><source>Bioorg Med Chem Lett</source><volume>18</volume><fpage>3749</fpage><lpage>3751</lpage><pub-id pub-id-type="pmid">18515098</pub-id></citation></ref><ref id="pone.0004501-Lasunskaia1"><label>68</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lasunskaia</surname><given-names>EB</given-names></name><name><surname>Fridlianskaia</surname><given-names>II</given-names></name><name><surname>Guzhova</surname><given-names>IV</given-names></name><name><surname>Bozhkov</surname><given-names>VM</given-names></name><name><surname>Margulis</surname><given-names>BA</given-names></name></person-group><year>1997</year><article-title>Accumulation of major stress protein 70kDa protects myeloid and lymphoid cells from death by apoptosis.</article-title><source>Apoptosis</source><volume>2</volume><fpage>156</fpage><lpage>163</lpage><pub-id pub-id-type="pmid">14646550</pub-id></citation></ref><ref id="pone.0004501-Goodarzi1"><label>69</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodarzi</surname><given-names>K</given-names></name><name><surname>Goodarzi</surname><given-names>M</given-names></name><name><surname>Tager</surname><given-names>AM</given-names></name><name><surname>Luster</surname><given-names>AD</given-names></name><name><surname>von Andrian</surname><given-names>UH</given-names></name></person-group><year>2003</year><article-title>Leukotriene B4 and BLT1 control cytotoxic effector T cell recruitment to inflamed tissues.</article-title><source>Nat Immunol</source><volume>4</volume><fpage>965</fpage><lpage>973</lpage><pub-id pub-id-type="pmid">12949533</pub-id></citation></ref><ref id="pone.0004501-Cheung1"><label>70</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Cheung</surname><given-names>NS</given-names></name><name><surname>Karlsson</surname><given-names>P</given-names></name><name><surname>Wang</surname><given-names>JX</given-names></name><name><surname>Bienert</surname><given-names>M</given-names></name><name><surname>Oehme</surname><given-names>P</given-names></name><etal/></person-group><year>1994</year><article-title>Functional studies with substance P analogues: effects of N-terminal, C-terminal, and C-terminus-extended analogues of substance P on nicotine-induced secretion and desensitization in cultured bovine adrenal chromaffin cells.</article-title><source>J Neurochem</source><volume>62</volume><fpage>2246</fpage><lpage>2253</lpage><pub-id pub-id-type="pmid">7514649</pub-id></citation></ref><ref id="pone.0004501-Vaudry1"><label>71</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Vaudry</surname><given-names>D</given-names></name><name><surname>Gonzalez</surname><given-names>BJ</given-names></name><name><surname>Basille</surname><given-names>M</given-names></name><name><surname>Yon</surname><given-names>L</given-names></name><name><surname>Fournier</surname><given-names>A</given-names></name><etal/></person-group><year>2000</year><article-title>Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.</article-title><source>Pharmacol Rev</source><volume>52</volume><fpage>269</fpage><lpage>324</lpage><pub-id pub-id-type="pmid">10835102</pub-id></citation></ref><ref id="pone.0004501-Harfi1"><label>72</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Harfi</surname><given-names>I</given-names></name><name><surname>Corazza</surname><given-names>F</given-names></name><name><surname>D'Hondt</surname><given-names>S</given-names></name><name><surname>Sariban</surname><given-names>E</given-names></name></person-group><year>2005</year><article-title>Differential calcium regulation of proinflammatory activities in human neutrophils exposed to the neuropeptide pituitary adenylate cyclase-activating protein.</article-title><source>J Immunol</source><volume>175</volume><fpage>4091</fpage><lpage>4102</lpage><pub-id pub-id-type="pmid">16148159</pub-id></citation></ref><ref id="pone.0004501-Morita1"><label>73</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Morita</surname><given-names>K</given-names></name><name><surname>Sakakibara</surname><given-names>A</given-names></name><name><surname>Kitayama</surname><given-names>S</given-names></name><name><surname>Kumagai</surname><given-names>K</given-names></name><name><surname>Tanne</surname><given-names>K</given-names></name><etal/></person-group><year>2002</year><article-title>Pituitary adenylate cyclase-activating polypeptide induces a sustained increase in intracellular free Ca(2&#x0002b;) concentration and catechol amine release by activating Ca(2&#x0002b;) influx via receptor-stimulated Ca(2&#x0002b;) entry, independent of store-operated Ca(2&#x0002b;) channels, and voltage-dependent Ca(2&#x0002b;) channels in bovine adrenal medullary chromaffin cells.</article-title><source>J Pharmacol Exp Ther</source><volume>302</volume><fpage>972</fpage><lpage>982</lpage><pub-id pub-id-type="pmid">12183654</pub-id></citation></ref><ref id="pone.0004501-Gevaert1"><label>74</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gevaert</surname><given-names>K</given-names></name><name><surname>Vandekerckhove</surname><given-names>J</given-names></name></person-group><year>2000</year><article-title>Protein identification methods in proteomics.</article-title><source>Electrophoresis</source><volume>21</volume><fpage>1145</fpage><lpage>1154</lpage><pub-id pub-id-type="pmid">10786887</pub-id></citation></ref><ref id="pone.0004501-Colin1"><label>75</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Colin</surname><given-names>DA</given-names></name><name><surname>Mazurier</surname><given-names>I</given-names></name><name><surname>Sire</surname><given-names>S</given-names></name><name><surname>Finck-Barbancon</surname><given-names>V</given-names></name></person-group><year>1994</year><article-title>Interaction of the two components of leukocidin from Staphylococcus aureus with human polymorphonuclear leukocyte membranes: sequential binding and subsequent activation.</article-title><source>Infect Immun</source><volume>62</volume><fpage>3184</fpage><lpage>3188</lpage><pub-id pub-id-type="pmid">8039887</pub-id></citation></ref><ref id="pone.0004501-Meunier1"><label>76</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meunier</surname><given-names>O</given-names></name><name><surname>Falkenrodt</surname><given-names>A</given-names></name><name><surname>Monteil</surname><given-names>H</given-names></name><name><surname>Colin</surname><given-names>DA</given-names></name></person-group><year>1995</year><article-title>Application of flow cytometry in toxinology: pathophysiology of human polymorphonuclear leukocytes damaged by a pore-forming toxin from Staphylococcus aureus.</article-title><source>Cytometry</source><volume>21</volume><fpage>241</fpage><lpage>247</lpage><pub-id pub-id-type="pmid">8582246</pub-id></citation></ref><ref id="pone.0004501-BabaMoussa1"><label>77</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Baba Moussa</surname><given-names>L</given-names></name><name><surname>Werner</surname><given-names>S</given-names></name><name><surname>Colin</surname><given-names>DA</given-names></name><name><surname>Mourey</surname><given-names>L</given-names></name><name><surname>Pedelacq</surname><given-names>JD</given-names></name><etal/></person-group><year>1999</year><article-title>Discoupling the Ca(2&#x0002b;)-activation from the pore-forming function of the bi-component Panton-Valentine leucocidin in human PMNs.</article-title><source>FEBS Lett</source><volume>461</volume><fpage>280</fpage><lpage>286</lpage><pub-id pub-id-type="pmid">10567712</pub-id></citation></ref><ref id="pone.0004501-Jonsson1"><label>78</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Jonsson</surname><given-names>U</given-names></name><name><surname>Fagerstam</surname><given-names>L</given-names></name><name><surname>Ivarsson</surname><given-names>B</given-names></name><name><surname>Johnsson</surname><given-names>B</given-names></name><name><surname>Karlsson</surname><given-names>R</given-names></name><etal/></person-group><year>1991</year><article-title>Real-time biospecific interaction analysis using surface plasmon resonance and a sensor chip technology.</article-title><source>Biotechniques</source><volume>11</volume><fpage>620</fpage><lpage>627</lpage><pub-id pub-id-type="pmid">1804254</pub-id></citation></ref><ref id="pone.0004501-Muller1"><label>79</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Muller</surname><given-names>A</given-names></name><name><surname>Glattard</surname><given-names>E</given-names></name><name><surname>Taleb</surname><given-names>O</given-names></name><name><surname>Kemmel</surname><given-names>V</given-names></name><name><surname>Laux</surname><given-names>A</given-names></name><etal/></person-group><year>2008</year><article-title>Endogenous morphine in SH-SY5Y cells and the mouse cerebellum.</article-title><source>PLoS ONE</source><volume>3</volume><fpage>e1641</fpage><pub-id pub-id-type="pmid">18327293</pub-id></citation></ref><ref id="pone.0004501-Elias1"><label>80</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elias</surname><given-names>JE</given-names></name><name><surname>Gygi</surname><given-names>SP</given-names></name></person-group><year>2007</year><article-title>Target-decoy search strategy for increased confidence in large-scale protein identifications by mass spectrometry.</article-title><source>Nat Methods</source><volume>4</volume><fpage>207</fpage><lpage>214</lpage><pub-id pub-id-type="pmid">17327847</pub-id></citation></ref></ref-list><fn-group><fn fn-type="conflict"><p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p></fn><fn fn-type="financial-disclosure"><p><bold>Funding: </bold>Inserm, CNRS, Universite Louis Pasteur Strasbourg, The Delegation &#x000e0; la Recherche clinique des Hopitaux universitaires de Strasbourg (Grant 3150), Fondation Transplantation, French ministery de la recherche et de l'enseignement superieur, BRAHMS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</p></fn></fn-group></back></article> 